Advertisement
Review| Volume 119, P84-117, January 2022

Download started.

Ok

Disinfection methods against SARS-CoV-2: a systematic review

Published:October 18, 2021DOI:https://doi.org/10.1016/j.jhin.2021.07.014

      Summary

      Background

      Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019, has caused millions of deaths worldwide. The virus is transmitted by inhalation of infectious particles suspended in the air, direct deposition on mucous membranes and indirect contact via contaminated surfaces. Disinfection methods that can halt such transmission are important in this pandemic and in future viral infections.

      Aim

      To highlight the efficacy of several disinfection methods against SARS-CoV-2 based on up-to-date evidence found in the literature.

      Methods

      Two databases were searched to identify studies that assessed disinfection methods used against SARS-CoV-2. In total, 1229 studies were identified and 60 of these were included in this review. Quality assessment was evaluated by the Office of Health Assessment and Translation's risk-of-bias tool.

      Findings

      Twenty-eight studies investigated disinfection methods on environmental surfaces, 16 studies investigated disinfection methods on biological surfaces, four studies investigated disinfection methods for airborne coronavirus, and 16 studies investigated methods used to recondition personal protective equipment (PPE).

      Conclusions

      Several household and hospital disinfection agents and ultraviolet-C (UV-C) irradiation were effective for inactivation of SARS-CoV-2 on environmental surfaces. Formulations containing povidone-iodine can provide virucidal action on the skin and mucous membranes. In the case of hand hygiene, typical soap bars and alcohols can inactivate SARS-CoV-2. Air filtration systems incorporated with materials that possess catalytic properties, UV-C devices and heating systems can reduce airborne viral particles effectively. The decontamination of PPE can be conducted safely by heat and ozone treatment.

      Keywords

      Introduction

      The coronavirus disease 2019 (COVID-19) pandemic has become an ongoing global health crisis responsible for causing millions of deaths and has devastated the world's economy [
      • Mofijur M.
      • Fattah I.M.R.
      • Alam M.A.
      • Islam A.B.M.S.
      • Ong H.C.
      • Rahman S.M.A.
      • et al.
      Impact of COVID-19 on the social, economic, environmental and energy domains: lessons learnt from a global pandemic.
      ,
      • World Health Organization
      COVID-19 weekly epidemiological update.
      ]. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel betacoronavirus, is known to be transmitted through exposure to infectious particles in respiratory droplets of infected individuals [
      • Lu R.
      • Zhao X.
      • Li J.
      • Niu P.
      • Yang B.
      • Wu H.
      • et al.
      Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
      ]. This can take place by inhalation of viral particles suspended in the air, deposition of exhaled infectious droplets directly on mucous membranes, or indirect contact with contaminated secondary surfaces, such as hands or fomites [
      Centers for Disease Control and Prevention
      Scientific brief: SARS-CoV-2 transmission.
      ]. It is believed that airborne transmission may be the dominant form of transmission that best explains the occurrence of superspreading events, the higher risk of transmission in indoor settings, and the fact that more than half of transmission events are observed in asymptomatic or pre-symptomatic patients [
      • Bulfone T.C.
      • Malekinejad M.
      • Rutherford G.W.
      • Razani N.
      Outdoor transmission of SARS-CoV-2 and other respiratory viruses: a systematic review.
      ,
      • Greenhalgh T.
      • Jimenez J.L.
      • Prather K.A.
      • Tufekci Z.
      • Fisman D.
      • Schooley R.
      Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
      ,
      • Johansson M.A.
      • Quandelacy T.M.
      • Kada S.
      • Prasad P.V.
      • Steele M.
      • Brooks J.T.
      • et al.
      SARS-CoV-2 transmission from people without COVID-19 symptoms.
      ,
      • Lewis D.
      Superspreading drives the COVID pandemic – and could help to tame it.
      ]. Particles emitted from infected individuals can be deposited on environmental surfaces and can remain viable for hours to days; as such, it is possible that transmission occurs due to indirect contact with contaminated surfaces [
      • World Health Organization
      Transmission of SARS-CoV-2: implications for infection prevention precautions.
      ,
      • van Doremalen N.
      • Bushmaker T.
      • Morris D.H.
      • Holbrook M.G.
      • Gamble A.
      • Williamson B.N.
      • et al.
      Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1.
      ,
      • Mondelli M.U.
      • Colaneri M.
      • Seminari E.M.
      • Baldanti F.
      Bruno R. Low risk of SARS-CoV-2 transmission by fomites in real-life conditions.
      ].
      The process of decontaminating surfaces normally uses chemical agents such as alcohol or quaternary ammonium compounds (QACs). There is evidence that these agents are active against viruses including SARS-CoV-2 [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ]. The World Health Organization (WHO) recommends alcohol-based formulations to disinfect hands; such formulations have been shown to inactivate SARS-CoV-2 efficiently [
      • Kratzel A.
      • Todt D.
      • V’Kovski P.
      • Steiner S.
      • Gultom M.
      • Thao T.T.N.
      • et al.
      Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
      ]. Many other accessible formulations with a broad range of application, such as hydrogen peroxide or povidone-iodine (PVP-I), possess antiviral properties, potentially serving as effective alternatives for the disinfection of biological surfaces [
      • Mentel R.
      • Shirrmakher R.
      • Kevich A.
      • Dreĭzin R.S.
      • Shmidt I.
      Virus inactivation by hydrogen peroxide.
      ,
      • Sriwilaijaroen N.
      • Wilairat P.
      • Hiramatsu H.
      • Takahashi T.
      • Suzuki T.
      • Ito M.
      • et al.
      Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
      ].
      As recent findings suggest that the airborne route is the most plausible and dominant form of transmission, this matter should be highlighted, and methods that can inactivate viruses suspended in the air may contribute substantially to lower the number of cases. Besides natural and mechanical ventilation, only two methods are available commercially: air cleaners fitted with filters or ultraviolet light; and upper room fixtures of ultraviolet germicidal irradiation (UVGI) [
      • Nardell E.A.
      • Nathavitharana R.R.
      Airborne spread of SARS-CoV-2 and a potential role for air disinfection.
      ]. UVGI uses short-wavelength ultraviolet C (UV-C) light which, in turn, has been tested against SARS-CoV-2 and proven to be effective [
      • Storm N.
      • McKay L.G.A.
      • Downs S.N.
      • Johnson R.I.
      • Birru D.
      • de Samber M.
      • al at
      Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation.
      ].
      Personal protective equipment (PPE) is essential to protect healthcare workers (HCWs) from contracting infections. Frontline HCWs are at higher risk of contracting SARS-CoV-2 infection compared with the general public [
      • Nguyen L.H.
      • Drew D.A.
      • Graham M.S.
      • Joshi A.D.
      • Guo C.
      • Ma W.
      • et al.
      Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.
      ]. While it is recommended that PPE should be disposable, in times of crisis, a shortage of PPE can cause more harm than benefit, as observed in many countries during the COVID-19 pandemic [
      • Burki T.
      Global shortage of personal protective equipment.
      ]. In cases when PPE is scarce, methods that provide proper sterilization, while preserving functionality, can be highly beneficial.
      The first vaccines, distributed by the end of 2020, have reduced the number of hospitalizations, deaths and incidence of infection, proving to be the most effective tool to combat the COVID-19 pandemic [
      • Haas E.J.
      • Angulo F.J.
      • McLaughlin J.M.
      • Anis E.
      • Singer S.R.
      • Khan F.
      • et al.
      Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
      ,
      • Moghadas S.M.
      • Vilches T.N.
      • Zhang K.
      • Wells C.R.
      • Shoukat A.
      • Singer B.H.
      • et al.
      The impact of vaccination on COVID-19 outbreaks in the United States.
      ,
      • Tenforde M.W.
      • Olson S.M.
      • Self W.H.
      • Talbot H.K.
      • Lindsell C.J.
      • Steingrub J.S.
      • et al.
      ]. However, disinfection methods will continue to play a major role and must still be put into practice to control local transmissions, whether from human to human, fomites or airborne. Halting the chain of transmission through the implementation of disinfection methods is not only useful in this present pandemic but also in any future similar pandemic. Therefore, the goal of this systematic review is to highlight the best disinfection methods to eliminate SARS-CoV-2 from environmental surfaces, biological surfaces and the air, and to determine the best methods to recondition PPE adequately.

      Methods

      Eligibility criteria

      This review included original articles and experimental studies. Guidelines, protocols, recommendations and non-experimental studies, such as case reports, case series, cross-sectional, prospective case–control studies, opinions and review articles, were excluded. No limitations were considered regarding language, date or status of publication.

      Participants

      Studies that mentioned SARS-CoV-2 as the main target of any type of disinfection method tested were included. If the study did not mention SARS-CoV-2 specifically, inclusion of the family of coronaviruses that shares genetic or morphological similarities with SARS-CoV-2, preferentially the betacoronaviruses responsible for previous outbreaks of respiratory diseases such as severe acute respiratory syndrome (SARS-CoV) and/or Middle Eastern respiratory syndrome (MERS-CoV), was mandatory. During an outbreak of a highly contagious viral disease such as COVID-19, the availability of the virus under investigation can be limited. Therefore, surrogate viruses (i.e. enveloped virus references) used to study the efficacy of disinfection methods were also included. Studies that did not meet the participant criteria were excluded.

      Interventions

      Trials that compared the virucidal effects of disinfection methods with the potential to halt transmission of SARS-CoV-2 on environmental surfaces, biological surfaces, air and PPE were assessed.

      Information sources, search and study selection

      A search was conducted by two reviewers in two separate databases from January to June 2021. PubMed and Web of Science were searched using the following terms: (‘SARS-CoV-2’ OR ‘Coronavirus’ OR ‘COVID-19’) AND (‘Disinfection Methods’ OR’ Surface Disinfection’ OR ‘Hand Disinfection’ OR ‘Air disinfection’ OR ‘Environmental disinfection’ OR ‘Inactivation’). Thirteen articles were identified from other sources and included in the screening process. Two reviewers screened (by title and abstract) the initial 1229 articles found, and the information collected was registered on a shared EndNote Vx9 (Clarivate Analytics, Philadelphia, PA, USA) library and a shared online Microsoft Excel V16.42/2020 (Microsoft Corp., Redmond, WA, USA) document. Eligibility assessment was performed independently in an unblinded standardized manner by two reviewers and disagreements between reviewers were solved by consensus. In total, 60 articles were found to meet the inclusion criteria and were included in this systematic review.

      Risk of bias

      To determine the risk of bias in the individual studies selected, the Office of Health Assessment and Translation Risk-of-Bias Rating Tool for Human and Animal Studies was used. This tool includes a questionnaire aimed to study risk of bias in several domains:
      • selection bias;
      • performance bias;
      • attrition/exclusion bias;
      • detection bias;
      • selective reporting bias; and
      • other bias.
      Potential source of bias was graded as low risk (++), probable low risk (+), probable high risk or not reported (-), and high risk (--).

      Results

      Study selection

      In total, 1229 articles were identified through a search of two databases, PubMed and Web of Science, from January 2021; 13 of these articles were included from other sources. After eliminating duplicate articles, 1021 articles remained. All articles were screened based on the title and abstract, leaving 83 articles eligible for this review. A further 36 articles were eliminated as they did not meet the inclusion criteria. In total, 60 articles were included in this systematic review. The details of this process are represented in Figure 1. The main characteristics of each individual study included in the systematic review are summarized in Table I.
      Figure 1
      Figure 1PRISMA flow diagram of included articles. SARS-CoV-2, severe acute respiratory syndrome coronavirus-2.
      Table ICharacteristics of included studies (N=60)
      StudyCountryYearStudy designEnvironmental surfacesPersonal protective equipment (masks/respirators etc.)Biological surfaces (hands, skin, oral cavity, respiratory tract)Air
      Anderson et al.UK2020In vitroX
      Bedell et al.USA2016In vitroX
      Behzadinasab et al.Hong Kong2020In vitroX
      Biryukov et al.USA2020In vitroXx
      Casanova et al.USA2010In vitroX
      Colnago et al.Brasil2020In vitroXx
      Criscuolo et al.Italy2020In vitroX
      Gamble et al.USA2020In vitroX
      GerchmanIsrael2020In vitroX
      He et al.China2004In vitrox
      Heilingloh et al.Germany2020In vitroX
      Hulkower et al.USA2011In vitroXx
      Khaiboullina et al.USA2020In vitroX
      Liu et al.China2020In vitroX
      MalenovskáCzech Republic2020In vitroX
      Martins et al.Brasil2020In vitroX
      Meyers et al.USA2021In vitroX
      Monge et al.USA2020In vitroX
      Rabenau et al.Germany2005In vitroXx
      Ratnesar-Shumate et al.USA2020In vitroX
      Wood and PayneUK1998In vitroX
      Blanchard et al.USA2020In vitroX
      Campos et al.USA2020In vitroX
      Buonanno et al.USA2020In vitroX
      Daeschler et al.Canada2020In vitroX
      Gopal et al.USA2020In vitroX
      Ibanez-Cervantes et al.Mexico2020In vitroX
      Ludwig-Begall et al.Belgium2020In vitroX
      Ma et al.China2020In vitroX
      Mantlo et al.USA2020In vitroX
      Ozog et al.USA2020In vitroX
      Perkins et al.USA2020In vitroX
      Rathnasinghe et al.USA2020In vitroX
      Rockey et al.USA2020In vitroX
      Bidra et al.USA2020In vitroX
      Bidra et al.USA2020In vitroX
      Eggers et al.Germany2015In vitroX
      Frank et al.USA2020In vitroX
      Gudmundsdottir et al.Iceland2020In vitroX
      Kratzel et al.Germany2020In vitroX
      Leslie et al.USA2020In vitroX
      Liang et al.China2020In vivo and in vitroX
      Meister et al.Germany2020In vitroX
      Mukherjee et al.India2020In vitroX
      Buonanno et al.USA2020In vitrox
      Qiao et al.USA2020In vitrox
      Yu et al.USA2020In vitrox
      Franke et al.Germany2021In vitrox
      Gidari et al.Italy2021In vitrox
      Glasbrenner et al.USA2021In vitrox
      Hirose et al.Japan2020In vitrox
      Hu et al.China2021In vitrox
      Huang et al.USA2020Prospective cohortx
      Ijaz et al.USA2021In vitroxx
      Messina et al.Italy2021In vitrox
      Steinhauer et al.Germany2020In vitroxx
      Steinhauer et al.Germany2020In vitrox
      Trivellin et al.Italy2021In vitrox
      Uppal et al.USA2021In vitrox
      Valdez-Salas et al.Mexico2021In vitrox

      Study characteristics

      The studies included were from 15 countries. Thirty-eight studies used SARS-CoV-2 in their experiments, and the other studies depended on surrogate viruses to represent virucidal activities of some disinfection methods. Six of the articles included were pre-prints.

      Stability and survival of SARS-CoV-2 exposed to heat and high humidity

      SARS-CoV-2 can remain viable on glass, stainless steel and plastic for more than 3.5 h at ambient temperature and humidity [
      • Gidari A.
      • Sabbatini S.
      • Bastianelli S.
      • Pierucci S.
      • Busti C.
      • Bartolini D.
      • et al.
      SARS-CoV-2 survival on surfaces and the effect of UV-C light.
      ]. Increasing relative humidity alone at a constant temperature of 25°C can reduce the survival of SARS-CoV-2 on non-porous surfaces from approximately 15 h–8 h. When temperature and relative humidity are increased simultaneously, the half-life can be reduced remarkably to approximately 1 h [
      • Biryukov J.
      • Boydston J.A.
      • Dunning R.A.
      • Yeager J.J.
      • Wood S.
      • Reese A.L.
      • et al.
      Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces.
      ]. The findings of another study conducted on other coronaviruses [mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV)] revealed similar results. However, at low temperatures of 4°C and relative humidity of 20%, viruses can persist for up to 28 days [
      • Casanova L.M.
      • Jeon S.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Effects of air temperature and relative humidity on coronavirus survival on surfaces.
      ]. SARS-CoV-2 can be deactivated at different rates when exposed to distinct heating procedures; one study showed that conditions that block evaporation can speed up virus inactivation rates substantially [
      • Gamble A.
      • Fischer R.J.
      • Morris D.H.
      • Yinda K.C.
      • Munster V.J.
      • Lloyd-Smith J.O.
      Heat-treated virus inactivation rate depends strongly on treatment procedure.
      ].

      Disinfection methods on environmental surfaces

      Amongst all the reviewed and included studies, 28 articles were categorized as disinfection methods with potential activity on environmental surfaces [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Gidari A.
      • Sabbatini S.
      • Bastianelli S.
      • Pierucci S.
      • Busti C.
      • Bartolini D.
      • et al.
      SARS-CoV-2 survival on surfaces and the effect of UV-C light.
      ,
      • Biryukov J.
      • Boydston J.A.
      • Dunning R.A.
      • Yeager J.J.
      • Wood S.
      • Reese A.L.
      • et al.
      Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces.
      ,
      • Casanova L.M.
      • Jeon S.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Effects of air temperature and relative humidity on coronavirus survival on surfaces.
      ,
      • Gamble A.
      • Fischer R.J.
      • Morris D.H.
      • Yinda K.C.
      • Munster V.J.
      • Lloyd-Smith J.O.
      Heat-treated virus inactivation rate depends strongly on treatment procedure.
      ,
      • Wood A.
      • Payne D.
      The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses.
      ,
      • Rabenau H.F.
      • Kampf G.
      • Cinatl J.
      • Doerr H.W.
      Efficacy of various disinfectants against SARS coronavirus.
      ,
      • Hulkower R.L.
      • Casanova L.M.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Inactivation of surrogate coronaviruses on hard surfaces by health care germicides.
      ,
      • Bedell K.
      • Buchaklian A.H.
      • Perlman S.
      Efficacy of an automated multiple emitter whole-room ultraviolet-C disinfection system against coronaviruses MHV and MERS-CoV.
      ,
      • Anderson E.R.
      • Hughes G.L.
      • Patterson E.I.
      Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.
      ,
      • Behzadinasab S.
      • Chin A.
      • Hosseini M.
      • Poon L.
      • Ducker W.A.
      A surface coating that rapidly inactivates SARS-CoV-2.
      ,
      • Colnago L.A.
      • Trevisol I.M.
      • Voss Rech D.
      • Forato L.A.
      • Igreja do Nascimento Mitre C.
      • Gagliardi L.J.P.
      • et al.
      Simple, low-cost and long-lasting film for virus inactivation using avian coronavirus model as Challenge.
      ,
      • Gerchman Y.
      • Mamane H.
      • Friedman N.
      • Mandelboim M.
      UV-LED disinfection of coronavirus: wavelength effect.
      ,
      • Heilingloh C.S.
      • Aufderhorst U.W.
      • Schipper L.
      • Dittmer U.
      • Witzke O.
      • Yang D.
      • et al.
      Susceptibility of SARS-CoV-2 to UV irradiation.
      ,
      • Khaiboullina S.
      • Uppal T.
      • Dhabarde N.
      • Subramanian V.R.
      • Verma S.C.
      Inactivation of human coronavirus by titania nanoparticle coatings and UVC radiation: throwing light on SARS-CoV-2.
      ,
      • Liu S.F.
      • Luo W.
      • Li D.
      • Yuan Y.
      • Tong W.
      • Kang J.J.
      • et al.
      Sec-eliminating the SARS-CoV-2 by AlGaN based high power deep ultraviolet light source.
      ,
      • Malenovská H.
      Coronavirus persistence on a plastic carrier under refrigeration conditions and its reduction using wet wiping technique, with respect to food safety.
      ,
      • Martins R.B.
      • Castro I.A.
      • Pontelli M.
      • Souza J.P.
      • Lima T.M.
      • Melo S.R.
      • et al.
      SARS-CoV-2 inactivation by ozonated water: a preliminary alternative for environmental disinfection.
      ,
      • Meyers C.
      • Kass R.
      • Goldenberg D.
      • Milici J.
      • Alam S.
      • Robison R.
      Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
      ,
      • Monge F.A.
      • Jagadesan P.
      • Bondu V.
      • Donabedian P.L.
      • Ista L.
      • Chi E.Y.
      • et al.
      Highly effective inactivation of SARS-CoV-2 by conjugated polymers and oligomers.
      ,
      • Ratnesar-Shumate S.
      • Williams G.
      • Green B.
      • Krause M.
      • Holland B.
      • Wood S.
      • et al.
      Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces.
      ,
      • Criscuolo E.
      • Diotti R.A.
      • Ferrarese R.
      • Alippi C.
      • Viscardi G.
      • Signorelli C.
      • et al.
      Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials.
      ,
      • Franke G.
      • Knobling B.
      • Brill F.H.
      • Becker B.
      • Klupp E.M.
      • Belmar Campos C.
      • et al.
      An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2.
      ,
      • Hu X.
      • Chen Z.
      • Su Z.
      • Deng F.
      • Chen X.
      • Yang Q.
      • et al.
      Ozone water is an effective disinfectant for SARS-CoV-2.
      ,
      • Messina G.
      • Della Camera A.
      • Ferraro P.
      • Amodeo D.
      • Corazza A.
      • Nante N.
      • et al.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
      ,
      • Trivellin N.
      • Buffolo M.
      • Onelia F.
      • Pizzolato A.
      • Barbato M.
      • Orlandi V.T.
      • et al.
      Inactivating SARS-CoV-2 using 275 nm UV-C LEDs through a spherical irradiation box: design, characterization and validation.
      ,
      • Uppal T.
      • Khazaieli A.
      • Snijders A.M.
      • Verma S.C.
      Inactivation of human coronavirus by FATHHOME's dry sanitizer device: rapid and eco-friendly ozone-based disinfection of SARS-CoV-2.
      ]. A summary of this category is provided in Table II.
      Table IIResults of disinfection methods used on environmental surfaces
      StudyVirusDisinfectantDisinfection phaseExposure timeReduction of viral infectivity (log10) or (%)Reduction of viral half-life (t1/2)
      1Anderson et al. (2020)SARS-CoV-2Virusend (TX-10) detergentSuspension test and stainless steel disc surface1 min4.0 log10(-)
      10 min4.0 log10
      2Bedell et al. (2016)MHV-A59Multiple-emitter, automated, continuous, whole-room UV-C disinfection systemGlass coverslip surface5 min2.71 log10(-)
      10 min6.11 log10
      MERS-CoV5 min5.91 log10
      10 min(-)
      3Behzadinasab et al. (2020)SARS-CoV-2Cu2O/PU coating filmGlass surface1 h3.64 log10(-)
      Stainless steel surface2.97 log10
      4Biryukov et al. (2020)SARS-CoV-224°C + 20% relative humidityStainless steel, ABS plastic and nitrile rubber surfaces(-)(-)15.33 h ± 2.75
      24°C + 40% relative humidity11.52 h ± 1.72
      24°C + 60% relative humidity9.15 h ± 3.39
      24°C + 80% relative humidity8.33 h ± 1.80
      35°C + 20% relative humidity7.33 h ± 1.33
      35°C + 40% relative humidity7.52 h ± 1.22
      35°C + 60% relative humidity2.26 h ± 1.42
      5Casanova et al. (2010)TGEV and MHV4°C + 20% relative humidityStainless steel surface28 days0.5 log10(-)
      4°C + 50% relative humidity21 days3.5 log10
      4°C + 80% relative humidity28 days3.2 log10 (TGEV) and 2.5 log10 (MHV)
      20°C + 20% relative humidity28 days2 log10
      20°C + 50% relative humidity3 days (TGEV) and 5 days (MHV)2 log10 (TGEV) and 3 log10 (MHV)
      20°C + 80% relative humidity14 days (TGEV) 11 days (MHV)3 log10 (TGEV) and 5 log10 (MHV)
      40°C + 20% relative humidity5 days3.5 log10 (TGEV) and 4.7 log10 (MHV)
      40°C + 50% relative humidity(-)(-)
      40°C + 80% relative humidity3 h2.8 log10 (TGEV) and 4.1 log10 (MHV)
      6Colnago et al. (2020)ACoVHousehold dishwashing detergent (2% sodium dodecyl sulfate and 6% linear alkylbene sulfonates)Suspension test10 min>4 log10(-)
      7Criscuolo et al. (2021)SARS-CoV-2UV-CGlass15 min>99.9%(-)
      Plastic>99.9%
      Gauze>99.9%
      Wood0.0%
      Fleece90.0%
      Wool94.4%
      Ozone (0.2 ppm)Glass2 h90.0%
      Plastic82.2%
      Gauze96.8%
      Wood93.3%
      Fleece>99.9%
      Ozone (4 ppm)Glass2 h94.4%
      Plastic90.0%
      Gauze99.8%
      Wood(-)
      Fleece99.7%
      8Gamble et al. (2020)SARS-CoV-2Uncovered plate oven (70°C)Suspension test(-)(-)∼37 min
      Covered plate oven (70°C)∼3 min and 56 s
      Closed vial oven (70°C)∼51.6 s
      Closed vial heat block (70°C)∼1 min and 55 s
      9Gerchman et al. (2020)HCoV-OC43UV-LED (267 nm wavelength, 6–7 mJ/cm2)Suspension test60 s>3 log10(-)
      UV-LED (279 nm wavelength, 6–7 mJ/cm2)>3 log10
      UV-LED (286 nm wavelength, 13 mJ/cm2)90 s>3 log10
      UV-LED (297 nm wavelength, 32 mJ/cm2)>3 log10
      10Heilingloh et al. (2020)SARS-CoV-2UV-C 1.94 mJ/cm2/sSuspension test9 minTotal inactivation(-)
      UV-A 0.54 mJ/cm2/s1 log reduction
      combined (UV-C and UV-A)Total inactivation
      11Hulkower et al. (2011)TGEV9.09% O-phenylphenol, 7.66% P-tertiary amylphenolStainless steel surface1 min2.03 log10(-)
      6% sodium hypochlorite0.35 log10
      0.55% ortho-phthalaldehyde2.27 log10
      70% ethanol3.19 log10
      62% ethanol4.04 log10
      71% ethanol3.51 log10
      MHV9.09% O-phenylphenol, 7.66% P-tertiary amylphenol1.33 log10
      6% sodium hypochlorite0.62 log10
      0.55% ortho-phthalaldehyde1.71 log10
      70% ethanol3.92 log10
      62% ethanol2.66 log10
      71% ethanol1.98 log10
      12Khaiboullina et al. (2020)HCoVTNP coating + UV-C (254 nm wavelength)Glass coverslip surfaceTNP (20 min to dry or left wet) o and UV-C (30 s and 1 minute)Reduction in viral copies on both wet and dry surfaces potentiated by the addition of TNP(-)
      13Liu et al. (2020)SARS-CoV-2Ultra-high power UV-CSuspension test1 s100%(-)
      14Malenovská (2020)SARS-CoV-299% water, caprylyl/capryl glucoside, citric acid, sodium citrate, sodium benzoatePlastic (4°C)24 h∼1.9 log10(-)
      48 h∼2.6 log10
      72 h∼2.2 log10
      96 h>1 log10
      120>0.3 log10
      Water, ethanol (0.6 g/wipe), glycerine, Aloe barbadensis leaf extract, chlorhexidine digluconate24 h2.4 log10
      48 h2.2 log10
      72 h>1.8 log10
      96 h>1 log10
      120 h>0.3 log10
      0.75% didecyl-dimethyl-ammonium chloride, 0.5% hydrogen peroxide, less than 5% non-ionic surface active agent, cationic surface active agent, bleaching agent based on oxygen, perfume, limonene, iodopropynyl butylcarbamate24 h>3.3 log10
      48 h>3.1 log10
      72 h>2.3 log10
      96 hNot performed
      120 hNot performed
      15Martins et al. (2020)SARS-CoV-2Ozonated water [0.2–0.8 ppm (mg/L)]Suspension test1 min2 log10(-)
      16Meyers et al. (2021)HCoV62% ethanolPorcelain surface15 s, 30 s, 1 min>4 log10, >4 log10, >4 log10(-)
      70% ethanol>4 log10, >4 log10,>4 log10
      75% ethanol>4 log10, >4 log10, >4 log10
      80% ethanol>4 log10, ≥4 log10, >4 log10
      95% ethanol>2 log10, 2–3 log10, 1–2 log10
      70% isopropanol>4 log10, >4 log10, >4 log10
      75% isopropanol>4 log10, >4 log10, >4 log10
      80% isopropanol>4 log10, >4 log10,>4 log10
      95% isopropanol>4 log10, 3–4 log10, 3–4 log10
      0.0525% sodium hypochlorite1–2 log10, 2–3 log10, 2–3 log10
      0.525% sodium hypochlorite>4 log10, >4 log10, >4 log10
      0.1% sodium hypochloriteNot performed
      Glutaraldehyde>4 log10, >4 log10, >4 log10
      62% ethanolCeramic surface>4 log10, >4 log10, >4 log10
      70% ethanol>4 log10, >4 log10, >4 log10
      75% ethanol3–4 log10, >4 log10, >4 log10
      80% ethanol>4 log10, >4 log10, >4 log10
      95% ethanol1–2 log10, 1–2 log10, 1–2 log10
      70% isopropanol>4 log10, 3–4 log10, >4 log10
      75% isopropanol>4 log10, >4 log10, >4 log10
      80% isopropanol>4 log10, >4 log10, >4 log10
      95% isopropanol3–4 log10, 1–2 log10, 1–2 log10
      0.0525% sodium hypochlorite1–3 log10, 1–2 log10, 1–2 log10
      0.525% sodium hypochlorite>4 log10, >4 log10, >4 log10
      0.1% sodium hypochlorite>4 log10, >4 log10, >4 log10
      Glutaraldehyde>4 log10, >4 log10, >4 log10
      17Monge et al. (2020)SARS-CoV-2Cationic phenylene ethynylene polymers (conjugated electrolytes)Suspension test10 min1–5 log(-)
      Cationic phenylene ethynylene oligomers (conjugated electrolytes)20 min1.5 log
      60 min5 log
      18Rabenau et al. (2005)SARS-CoVMikrobac forte (0.5% benzalkonium chloride and laurylamine)Suspension test30 min≥6.13 log10(-)
      Korsolin FF (0.5% benzalkonium chloride, glutaraldehyde and didecyldimonium chloride)≥3.75 log10
      Dismozon pur (magnesium monoperphthalate)≥4.5 log10
      Korsolex basic [4% glutaraldehyde and (ethylenedioxy) dimethanol]15 min≥3.5 log10
      Korsolex basic [3% glutaraldehyde and (ethylenedioxy) dimethanol]30 min≥3.5 log10
      Korsolex basic [2% glutaraldehyde and (ethylenedioxy) dimethanol]60 min≥3.5 log10
      19Ratnesar-Shumate et al. (2020)SARS-CoV-237°C + 5% CO2Stainless steel coupons20 min1.6 W/m2 UV-B ->∼2.5 log10(-)
      0.7 W/m2 UV-B ->∼2.2 log10
      0.3 W/m2 UV-B ->∼2.5 log 10
      Darkness ->0.5 log10
      20Wood and Payne (1998)HCoVDettol (5% chloroxylenol)Suspension test1 min0.0 log10(-)
      Dettol for hospitals (1% benzalkonium chloride)0.0 log10
      Savlon (5% cetrimide and chlorhexidine gluconate)0.0 log10
      21Franke et al. (2021)Bacteriophage F6 (phi 6)Ozone (80 ppm) + 90% relative humidityMelamine-coated solid core panels60 min4.29 log10(-)
      Ceramic tiles6.15 log10
      Stainless steel carriers5.31 log10
      Bovine coronavirusMelamine-coated solid core panels5.03 log10
      Ceramic tiles4.88 log10
      Stainless steel carriers5.31 log10
      22Gidari et al. (2021)SARS-CoV-223–25°C + 40–50 relative humidityPlastic(-)(-)3.5 h
      Stainless steel carriers4.4 h
      Glass4.2 h
      UV-C (254 nm)Plastic20.06 mJ/cm2 (36 s)>4.00 log10(-)
      Stainless steel carriers20.06 mJ/cm2 (36 s)>4.00 log10
      Glass10.25 mJ/cm2 (21 s)>4.00 log10
      23Hu et al. (2021)SARS-CoV-2Ozonated water (36 mg/L)Suspension test0 min0.0 log10(-)
      1 min∼5 log10
      5 min∼5 log10
      10 min∼5 log10
      Ozonated water (18 mg/L)1 min∼5 log10
      24Ijaz et al. (2020)MHV-10.12% p-chloro-m-xylenol (PCMX)Glass0.5 min≥4.2 log10(-)
      HCoV-229E10 min≥4.0 log10
      SARS-CoV5 min≥6.0 log10
      MERS-CoV5 min≥5.0 log10
      SARS-CoV-2Suspension test1 min≥5.0 log10
      HCoV-229E (1), SARS-CoV (2), SARS-CoV-2 (3)PCMX (0.125% w/v)Glass + organic load5–10 min(1) ≥4.0 log10, (2) ≥6.0 log10, (3) not performed
      Alkyl dimethyl benzyl ammonium chloride QAC (0.19% w/w)1.75 min(1) ≥6.0 log10, (2) ≥5.8 log10, (3) ≥3.5 log10
      Citric acid (2.4% w/w)0.5 min(1) ≥4.3 log10, (2) ≥3.0 log10, (3) ≥3.0 log10
      Ethanol (50% w/w)/QAC (0.082% w/w)0.5–1.75 min(1) ≥5.5 log10, (2) not performed, (3) ≥4.5 log10
      Alkyl dimethyl benzyl ammonium chloride (0.0916%)5 min(1) ≥3.5 log10, (2) ≥4.8 log10, (3) not performed
      QAC (0.092% w/w)2 min(1) ≥3.3 log10, (2) ≥3.8 log10, (3) ≥4.0 log10
      HCoV-229E (1), SARS-CoV-2 (2)QAC (0.077% w/w)Suspension test5 min(1) Not performed (2) ≥4.1 log10
      Lactic acid (1.9% w/w)5 min(1) Not performed (2) ≥5.5 log10
      Hydrochloric acid (0.25% w/w)0.5 min(1) Not performed (2) ≥4.1 log10
      Sodium hypochlorite (0.14% w/w)0.5 min(1) Not performed (2) ≥5.1 log10
      Benzalkonium chloride (0.45% w/w)5 min(1) Not performed (2) ≥4.5 log10
      Ethanol (44% w/w)5 min(1) ≥4.0 log10 (2) ≥4.1 log10
      Sodium hypochlorite (0.32% w/w)5 min(1) Not performed (2) ≥5.1 log10
      25Messina et al. (2021)SARS-CoV-2UV irradiation chips (265–350 nm) box with lid - reflected lightSuspension test3 min4.70 log10(-)
      UV irradiation chips (265–350 nm) box with lid3 min3.45 log10
      UV irradiation chips (265–350 nm) box with lid6 min5.53 log10
      UV irradiation chips (265–350 nm) box with lid6 min5.53 log10
      UV irradiation chips (265–350 nm) box with lid10 min5.70 log10
      UV irradiation chips (265–350 nm) box with lid10 min5.70 log10
      UV irradiation chips (265–350 nm) box without lid - direct light3 min4.62 log10
      UV irradiation chips (265–350 nm) box without lid3 min5.53 log10
      UV irradiation chips (265–350 nm) box without lid10 min5.70 log10
      UV irradiation chips (265–350 nm) box without lid10 min5.70 log10
      26Steinhauer et al. (2020)Modified vaccinia virus Ankara20% surface disinfectant - propan-2-ol, ethanolSuspension test15 s∼0 log10(-)
      90% surface disinfectant - propan-2-ol, ethanol15 s≥4.25 log10
      Vaccinia virus Elstree80% surface disinfectant - QAC30 s≥4.32 log10
      80% surface disinfectant - QAC60 s≥4.51 log10
      SARS-CoV-220% surface disinfectant - propan-2-ol, ethanol15 s≥4.02 log10
      80% surface disinfectant - propan-2-ol, ethanol15 s≥4.02 log10
      20% surface disinfectant - QAC15 s≥4.02 log10
      20% surface disinfectant - QAC60 s≥3.17 log10
      80% surface disinfectant - QAC15 s≥4.38 log10
      80% surface disinfectant - QAC30 s≥4.38 log10
      80% surface disinfectant - QAC60 s≥2.17 log10
      27Trivellin et al. (2020)SARS-CoV-2UV-C LED (275 nm) spherical irradiation boxFootball1 min>3 log10(-)
      2 min>3 log10
      Basketball1 min>3 log10
      2 min>3 log10
      Volleyball1 min>3 log10
      2 min>3 log10
      28Uppal et al. (2021)HCoV-OC43Ozone (20 ppm)Glass10 min90.71%(-)
      Ozone (25 ppm)10 min92.3245%
      15 min99.99%
      20 min100.00%
      Ozone (50 ppm)10 min99.987%
      15 min99.985%
      20 min100.00%
      SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; MHV, mouse hepatitis virus; MERS-COV, Middle East respiratory syndrome coronavirus; TGEV, transmissible gastroenteritis coronavirus; HCoV, human coronavirus; ACOV, avian coronavirus; UV-C, ultraviolet C irradiation; UV-A, ultraviolet A irradiation; UV-LED, ultraviolet light emitting diode; Cu2O/PU, cuprous oxide/polyurethane; TiO2, titanium dioxide; TNP, TiO2 nanoparticle; ABS plastic, acrylonitrile butadiene styrene plastic.
      Several studies demonstrated the virucidal properties of commonly used alcohols, leading to the inactivation of viruses on environmental surfaces. One study illustrated inactivation of human coronavirus (HCoV) on porcelain and ceramic surfaces with different concentrations of ethanol and isopropanol. Ethanol with concentrations ranging from 62% to 80% can cause a 4 log10 reduction of viral titres after exposure ≥15 s. Isopropanol 60–70% exposed on surfaces for at least 15 s demonstrated similar results with a 4 log10 reduction of viral titre [
      • Meyers C.
      • Kass R.
      • Goldenberg D.
      • Milici J.
      • Alam S.
      • Robison R.
      Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
      ]. Hulkower et al. demonstrated the virucidal effects of three products containing different concentrations of alcohol on stainless steel surfaces. Ethanol 62%, 70% and 71% showed approximately 1.98–3.92 log10 reduction of MHV and 3.19–4.04 log10 reduction of TGEV after 1 min of exposure [
      • Hulkower R.L.
      • Casanova L.M.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Inactivation of surrogate coronaviruses on hard surfaces by health care germicides.
      ]. Hygiene wipes containing water and ethanol (0.6 g/wipe) destined to decontaminate plastic food packaging can reduce alphacoronavirus 1 to undetectable levels after 72 h of refrigeration (4°C) compared with wipes containing 99% water. However, this study showed evidence that hygiene wipes can potentially transfer viral particles to secondary surfaces [
      • Malenovská H.
      Coronavirus persistence on a plastic carrier under refrigeration conditions and its reduction using wet wiping technique, with respect to food safety.
      ]. Only two studies showed virucidal efficacy with at least 20% ethanol against SARS-CoV-2 in suspension [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
      ].
      In the case of sodium hypochlorite, one study showed that 0.525% and 0.1% sodium hypochlorite was sufficient to produce a 4 log10 reduction of HCoV after 15 s of exposure on porcelain and ceramic surfaces [
      • Meyers C.
      • Kass R.
      • Goldenberg D.
      • Milici J.
      • Alam S.
      • Robison R.
      Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
      ]. Sodium hypochlorite 0.06% caused <1 log10 reduction of MHV and TGEV after 1 min of exposure on stainless steel. This indicates that either a higher concentration of sodium hypochlorite is needed to cause a more significant reduction in viral titre after 1 min of exposure or a longer exposure time should be considered if 0.06% sodium hypochlorite is used [
      • Hulkower R.L.
      • Casanova L.M.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Inactivation of surrogate coronaviruses on hard surfaces by health care germicides.
      ]. When it comes to SARS-CoV-2, 0.14% sodium hypochlorite has been shown to reduce the viral titre significantly after 30 s of exposure [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ].
      With reference to aldehydes, one study showed that glutaraldehyde can lead to a >4 log10 reduction in HCoV with contact times as low as 15 s on porcelain and ceramic surfaces [
      • Meyers C.
      • Kass R.
      • Goldenberg D.
      • Milici J.
      • Alam S.
      • Robison R.
      Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
      ]. Glutaraldehyde 4% and ethylenedioxy dimethanol at different concentrations were also capable of causing more than 3.5 log10 reduction in SARS-CoV titre after 15 min in a suspension test [
      • Rabenau H.F.
      • Kampf G.
      • Cinatl J.
      • Doerr H.W.
      Efficacy of various disinfectants against SARS coronavirus.
      ]. Ortho-phthalaldehyde (OPA) 0.55% caused <2.5 log10 reduction of MHV and TGEV after 1 min of exposure, indicating that OPA may need a longer exposure time to reach its total inactivation capacity [
      • Hulkower R.L.
      • Casanova L.M.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Inactivation of surrogate coronaviruses on hard surfaces by health care germicides.
      ].
      QACs are common disinfection agents with a wide range of microbicidal action. Disinfectant wipes containing 0.75% didecyl-dimethyl-ammonium chloride associated with 0.5% hydrogen peroxide can reduce the alphacoronavirus 1 titre by 3.8 log10 on plastic carriers, and can prevent transmission to secondary surfaces [
      • Malenovská H.
      Coronavirus persistence on a plastic carrier under refrigeration conditions and its reduction using wet wiping technique, with respect to food safety.
      ]. Combined surface disinfection solutions containing 0.5% benzalkonium chloride with laurylamine can reduce the SARS-CoV titre by 6.13 log10 after 30 min of exposure, while 0.5% benzalkonium chloride associated with glutaraldehyde and didecyldimonium chloride showed a 3.75 log10 reduction in the SARS-CoV titre in 30 min [
      • Rabenau H.F.
      • Kampf G.
      • Cinatl J.
      • Doerr H.W.
      Efficacy of various disinfectants against SARS coronavirus.
      ]. However, a study conducted in 1997 on suspended HCoV revealed that 1% of benzalkonium chloride and a combination of 5% cetrimide and chlorhexidine gluconate were both ineffective in reducing viral titre after 1 min of exposure [
      • Wood A.
      • Payne D.
      The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses.
      ]. Moreover, QACs were shown to be active against SARS-CoV-2, vaccinia virus Elstree and modified vaccinia virus Ankara with contact times ≤5 min [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
      ].
      Phenols are another group of disinfectants active against a variety of micro-organisms. Cleaners that consist of 9.09% O-phenylphenol and 7.66% P-tertiary amylphenol showed a moderate reduction in infectivity for MHV and TGEV, revealing approximately 0.8–3.17 log10 reduction on stainless steel surfaces [
      • Hulkower R.L.
      • Casanova L.M.
      • Rutala W.A.
      • Weber D.J.
      • Sobsey M.D.
      Inactivation of surrogate coronaviruses on hard surfaces by health care germicides.
      ]. Chloroxylenol 5% was ineffective for reducing the HCoV titre, but a study conducted in 2020 demonstrated that lower concentrations can efficiently inactivate a number of coronaviruses, including SARS-CoV-2, deposited on glass and in suspension after 1 min of exposure [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Wood A.
      • Payne D.
      The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses.
      ].
      Ozonated water could be an alternative for environmental disinfection as it can cause a 2.0–5.0 log10 reduction in SARS-CoV-2 titre after only 1 min of exposure [
      • Martins R.B.
      • Castro I.A.
      • Pontelli M.
      • Souza J.P.
      • Lima T.M.
      • Melo S.R.
      • et al.
      SARS-CoV-2 inactivation by ozonated water: a preliminary alternative for environmental disinfection.
      ,
      • Hu X.
      • Chen Z.
      • Su Z.
      • Deng F.
      • Chen X.
      • Yang Q.
      • et al.
      Ozone water is an effective disinfectant for SARS-CoV-2.
      ].
      Other chemical agents, such as magnesium monoperoxyphthalate, lead to a ≥4.5 log10 reduction in SARS-CoV titre after 15 min of exposure [
      • Rabenau H.F.
      • Kampf G.
      • Cinatl J.
      • Doerr H.W.
      Efficacy of various disinfectants against SARS coronavirus.
      ]. Surface disinfectants based on citric acid, hydrochloride acid or lactic acid were shown to reduce viral titres of coronaviruses (including SARS-CoV-2) efficiently [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ]. Virusend (TX-10), a detergent-based disinfectant, was able to reduce infectious SARS-CoV-2 with high titre inoculum by at least 4.0 log10 plaque-forming units (PFU)/mL, and reduce infectious SARS-CoV-2 with low titre inoculum by at least 2.3 log10 PFU/mL on hard surfaces, such as stainless steel, and in solution [
      • Anderson E.R.
      • Hughes G.L.
      • Patterson E.I.
      Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.
      ].

      UV-C irradiation and ozone exposure

      On glass surfaces, UV-C radiation can reduce MHV titre by an average of 2.71 log10 and 6.11 log10 with exposure times of 5 and 10 min, respectively. It is also able to reduce MERS-CoV titre by 5.9 log10 after 5 min of exposure [
      • Bedell K.
      • Buchaklian A.H.
      • Perlman S.
      Efficacy of an automated multiple emitter whole-room ultraviolet-C disinfection system against coronaviruses MHV and MERS-CoV.
      ]. Findings in two studies indicated that at least 3 min of exposure to UV-C irradiation is able to inactivate SARS-CoV-2 in suspension completely [
      • Heilingloh C.S.
      • Aufderhorst U.W.
      • Schipper L.
      • Dittmer U.
      • Witzke O.
      • Yang D.
      • et al.
      Susceptibility of SARS-CoV-2 to UV irradiation.
      ,
      • Messina G.
      • Della Camera A.
      • Ferraro P.
      • Amodeo D.
      • Corazza A.
      • Nante N.
      • et al.
      ]. Spherical objects such as footballs, volleyballs and basketballs were completely decontaminated from SARS-CoV-2 after 1 min of exposure to a UV-C-LED device (275 nm) [
      • Trivellin N.
      • Buffolo M.
      • Onelia F.
      • Pizzolato A.
      • Barbato M.
      • Orlandi V.T.
      • et al.
      Inactivating SARS-CoV-2 using 275 nm UV-C LEDs through a spherical irradiation box: design, characterization and validation.
      ]. UV-A, characterized by a longer wavelength (315–400 nm) is less efficient in viral inactivation, revealing only 1 log10 reduction after 9 min of exposure to radiation [
      • Heilingloh C.S.
      • Aufderhorst U.W.
      • Schipper L.
      • Dittmer U.
      • Witzke O.
      • Yang D.
      • et al.
      Susceptibility of SARS-CoV-2 to UV irradiation.
      ]. It is suggested that peak emission of approximately 286 nm can be effective in inactivating coronaviruses [
      • Gerchman Y.
      • Mamane H.
      • Friedman N.
      • Mandelboim M.
      UV-LED disinfection of coronavirus: wavelength effect.
      ]. An in-vitro study provided evidence that UV-B (280–315 nm) levels similar to natural sunlight can significantly reduce SARS-CoV-2 titre by 2.5 log10 on stainless steel surfaces after 20 min of exposure [
      • Ratnesar-Shumate S.
      • Williams G.
      • Green B.
      • Krause M.
      • Holland B.
      • Wood S.
      • et al.
      Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces.
      ].
      Exposure of glass, plastic and gauze samples infected with SARS-CoV-2 to UV-C irradiation for 15 min led to a 99.99% reduction of viral titre, while a reduction of 90–95% was obtained for fleece and wool samples. No reduction in viral titre was quantified on wood samples with this method [
      • Criscuolo E.
      • Diotti R.A.
      • Ferrarese R.
      • Alippi C.
      • Viscardi G.
      • Signorelli C.
      • et al.
      Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials.
      ]. In the same study, 2 h of exposure to ozone 0.2 ppm was able to completely disinfect (99.99% reduction) fleece samples, and to achieve a 96.8% reduction on gauze, 93.3% on wood, 90% on glass and 82.2% on plastic. Exposure of the same materials to higher concentrations of ozone was effective in reducing viral titre in a shorter period. Uppal et al. demonstrated that ozone gas of at least 25 ppm can optimally eliminate ≥99% of HCoV deposited on glass in 15 min, while another study showed that ozone 80 ppm and 90% relative humidity obtained significant viral inactivation after 60 min [
      • Franke G.
      • Knobling B.
      • Brill F.H.
      • Becker B.
      • Klupp E.M.
      • Belmar Campos C.
      • et al.
      An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2.
      ,
      • Uppal T.
      • Khazaieli A.
      • Snijders A.M.
      • Verma S.C.
      Inactivation of human coronavirus by FATHHOME's dry sanitizer device: rapid and eco-friendly ozone-based disinfection of SARS-CoV-2.
      ].
      Complete inactivation of HCoV is seen on TiO2 nanoparticle (TNP)-coated glass coverslips exposed to UV-C for 30 s and 1 min. Viral inactivation was enhanced and accelerated with TNP coating, making viral titres undetectable after shorter time exposures to UV-C irradiation [
      • Khaiboullina S.
      • Uppal T.
      • Dhabarde N.
      • Subramanian V.R.
      • Verma S.C.
      Inactivation of human coronavirus by titania nanoparticle coatings and UVC radiation: throwing light on SARS-CoV-2.
      ].
      SARS-CoV-2 can be eliminated completely after only 1 s of exposure to a high-powered deep UV light. The UV light source is an aluminium gallium nitride-based device and can achieve an output power as high as 2 W at a current of 1.3 A allowing the ultra-rapid inactivation of SARS-CoV-2 [
      • Liu S.F.
      • Luo W.
      • Li D.
      • Yuan Y.
      • Tong W.
      • Kang J.J.
      • et al.
      Sec-eliminating the SARS-CoV-2 by AlGaN based high power deep ultraviolet light source.
      ].

      Coatings and films

      Coating surfaces with cuprous oxide/polyurethane or conjugated electrolytes such as cationic phenylene ethynylene polymers and oligomers was shown to have virucidal activity against SARS-CoV-2, and reduce viral titre significantly after 1 h of exposure on glass, stainless steel and in suspension [
      • Behzadinasab S.
      • Chin A.
      • Hosseini M.
      • Poon L.
      • Ducker W.A.
      A surface coating that rapidly inactivates SARS-CoV-2.
      ,
      • Monge F.A.
      • Jagadesan P.
      • Bondu V.
      • Donabedian P.L.
      • Ista L.
      • Chi E.Y.
      • et al.
      Highly effective inactivation of SARS-CoV-2 by conjugated polymers and oligomers.
      ]. Films made from an accessible household dishwashing detergent containing 8% surfactant can provide longer virucidal activity on inanimate surfaces, reducing avian coronavirus to undetectable levels after 10 min of exposure. The activity of these films can persist for up to 7 days [
      • Colnago L.A.
      • Trevisol I.M.
      • Voss Rech D.
      • Forato L.A.
      • Igreja do Nascimento Mitre C.
      • Gagliardi L.J.P.
      • et al.
      Simple, low-cost and long-lasting film for virus inactivation using avian coronavirus model as Challenge.
      ].

      Disinfection methods on biological surfaces

      Sixteen articles addressed disinfection methods that can be used on biological surfaces (Table III) with application on skin, hands and mucous membranes, such as the oral cavity and upper respiratory tract [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Kratzel A.
      • Todt D.
      • V’Kovski P.
      • Steiner S.
      • Gultom M.
      • Thao T.T.N.
      • et al.
      Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
      ,
      • Rabenau H.F.
      • Kampf G.
      • Cinatl J.
      • Doerr H.W.
      Efficacy of various disinfectants against SARS coronavirus.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
      ,
      • Eggers M.
      • Eickmann M.
      • Zorn J.
      Rapid and effective virucidal activity of povidone-iodine products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA).
      ,
      • Bidra A.S.
      • Pelletier J.S.
      • Westover J.B.
      • Frank S.
      • Brown S.M.
      • Tessema B.
      Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses.
      ,
      • Bidra A.S.
      • Pelletier J.S.
      • Westover J.B.
      • Frank S.
      • Brown S.M.
      • Tessema B.
      Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse.
      ,
      • Frank S.
      • Brown S.M.
      • Capriotti J.A.
      • Westover J.B.
      • Pelletier J.S.
      • Tessema B.
      In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2.
      ,
      • Gudmundsdottir Á.
      • Scheving R.
      • Lindberg F.
      • Stefansson B.
      Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
      ,
      • Leslie R.A.
      • Zhou S.S.
      • Macinga D.R.
      Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers.
      ,
      • Liang B.
      • Yuan X.
      • Wei G.
      • Wang W.
      • Zhang M.
      • Peng H.
      • et al.
      In-vivo toxicity studies and in-vitro inactivation of SARS-CoV-2 by povidone-iodine in-situ gel forming formulations.
      ,
      • Meister T.L.
      • Brüggemann Y.
      • Todt D.
      • Conzelmann C.
      • Müller J.A.
      • Groß R.
      • et al.
      Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2.
      ,
      • Mukherjee S.
      • Vincent C.K.
      • Jayasekera H.W.
      • Yekhe A.S.
      Antiviral efficacy of personal care formulations against severe acute respiratory syndrome coronavirus 2.
      ,
      • Hirose R.
      • Bandou R.
      • Ikegaya H.
      • Watanabe N.
      • Yoshida T.
      • Daidoji T.
      • et al.
      Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation.
      ,
      • Huang Y.H.
      • Huang J.T.
      Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2.
      ].
      Table IIIResults of disinfection methods used on biological surfaces
      StudyVirusDisinfectantDisinfection phaseExposure timeReduction of viral infectivity (log10) or (%)Type
      1Bidra et al. (2020)SARS-CoV-2PVP-I 1.0% oral rinseST15 s and 30 s∼4.33 log10Oral
      PVP-I 2.5% oral rinse∼4.33 log10
      PVP-I 3.0% oral rinse∼4.33 log10
      H2O2 3.0%1.33 log10
      H2O2 6.0%1 log10
      2Bidra et al. (2020)SARS-CoV-2PVP-I (3.0%) oral rinse antisepticST30 s3.33 log10Oral
      PVP-I (1.5%) oral rinse antiseptic3.33 log10
      PVP-I (1.0%) oral rinse antiseptic3.33 log10
      3Eggers et al. (2015)MERS-CoVPVP-I surgical scrub (7.5 g/L available iodine)ST15 s4.64 log10Skin and oral
      PVP-I skin cleanser (4 g/L available iodine)4.97 log10
      PVP-I gargle and mouthwash (1 g/L available iodine)4.30 log10
      Modified vaccinia virus AnkaraPVP-I surgical scrub (7.5 g/L available iodine)15 s, 30 s and 60 s≥4.17 log10, ≥4.17 log10, ≥4.17 log10
      PVP-I skin cleanser (4 g/L available iodine)≥4.00 log10, ≥4.00 log10, ≥4.00 log10
      PVP-I gargle and mouthwash (1 g/L available iodine)≥6.50 log10, ≥6.50 log10, ≥6.50 log10
      4Frank et al. (2020)SARS-CoV-2PVP-I nasal antiseptic 5.0%Dilution test15 s and 30 s3 log10 (15 s), 3.33 log10 (30 s)Respiratory tract
      PVP-I nasal antiseptic 2.5%3 log 10 (15 s), 3.33 log10 (30 s)
      PVP-I nasal antiseptic 1.0%3log10 (15 s), 3.33 log10 (30 s)
      5Gudmundsdottir et al. (2020)SARS-CoV-2 and HCoVColdzyme (glycerol, water, cod trypsin, ethanol, calcium chloride, hydroxymethy, and menthol)ST20 min1.76 log 10 (SARS-CoV-2), 2.88 log10 (HCoV)Oral
      6Kratzel et al. (2020)SARS-CoV-2Original WHO formulation I consists of 80% (vol/vol) ethanol, 1.45% (vol/vol) glycerol, and 0.125% (vol/vol) hydrogen peroxideST30 s>3.8 log10Hands
      Original WHO formulation II consists of 75% (vol/vol) 2-propanol, 1.45% (vol/vol) glycerol, and 0.125% (vol/vol) hydrogen peroxide>3.8 log10
      Modified WHO formulation I consists of 80% (wt/wt) ethanol, 0.725% (vol/vol) glycerol, and 0.125% (vol/vol) hydrogen peroxide>5.9 log10
      Modified isopropyl-based WHO formulation II contains 75% (wt/wt) 2-propanol, 0.725% (vol/vol) glycerol, and 0.125% (vol/vol) hydrogen peroxide>5.9 log10
      7Leslie et al. (2020)SARS-CoV-2PURELL hand sanitizer gel, 70% ethanol (vol/vol)ST30 s≥3.22 log10Hands
      PURELL hand sanitizer foam, 70% ethanol (vol/vol)≥3.10 log10
      8Liang et al. (2020)SARS-CoV-2Povidone-iodine in-situ gel (polyvinylpyrrolidinone-iodine complex) (0.9%)ST in tear fluid30 s, 2 min and 10 min3.5 log10 (30 s), 2.9 log10 (2 min), 3.3 log10 (10 min)eyes
      Povidone-iodine in-situ gel (polyvinylpyrrolidinone-iodine complex) (0.5%)3.2 log10 (30 s), 2.9 log10 (2 min), 3.3 log10 (10 min)
      Povidone-iodine in-situ gel (polyvinylpyrrolidinone-iodine complex) (0.28%)2.2 log10 (30 s), 2.6 log10 (2 min), 3.3 log10 (10 min)
      Povidone-iodine in-situ gel (polyvinylpyrrolidinone-iodine complex) (0.09%)1.2 log10 (30 s), 0.8 log10 (2 min), 1.0 log10 (10 min)
      Povidone-iodine nasal spray (1-vinyl-2-pyrrolidinone polymers, iodine complex) (0.54%)ST in nasal fluid3.1 log10 (30 s), 2.9 log10 (2 min), 3.3 log10 (10 min)Respiratory tract
      Povidone-iodine nasal spray (1-vinyl-2-pyrrolidinone polymers, iodine complex) (0.3%)3.1 log10 (30 s), 2.9 log10 (2 min), 3.3 log10 (10 min)
      Povidone-iodine nasal spray (1-vinyl-2-pyrrolidinone polymers, iodine complex) (0.17%)2.9 log10 (30 s), 2.9 log10 (2 min), 3.3 log10 (10 min)
      Povidone-iodine nasal spray (1-vinyl-2-pyrrolidinone polymers, iodine complex) (0.05%)2.3 log10 (30 s), 1.9 log10 (2 min), 1.6 log10 (10 min)
      9Meister et al. (2020)SARS-CoV-2Cavex oral pre rinse (hydrogen peroxide)ST30 s0.33–0.78 logOral
      Chlorhexamed Forte [chlorhexidinebis (D-gluconate)]0.78–1.17 log
      Dequonal (dequalinium chloride, benzalkonium chloride)≥2.61–3.11 log
      Dynexidine Forte 0.2% [chlorhexidinebis (D-gluconate)]0.50–0.56 log
      Iso-betadine mouthwash 0% (polyvidone-iodine)≥2.61–3.11 log
      Listerine cool mint (ethanol, essential oils)≥2.61–3.11 log
      Octenident mouthwash (octenidine dihydrochloride)0.61–1.11 log
      ProntOral mouthwash (polyaminopropyl biguanide (polyhexanide)0.61–≥1.78 log
      10Mukherjee et al. (2020)SARS-CoV-2Soap bar with 67 total fatty matterST20 s≥3.14 log10Hands
      Soap bar with 68 total fatty matter20 s≥3.06 log10
      Soap bar with 72 total fatty matter20 s≥4.06 log10
      Liquid cleansers with 10% surfactant w/w20 s≥3.10 log10
      Liquid cleansers with 12% surfactant w/w10 s≥3.01 log10
      Liquid cleansers with 19% surfactant w/w10 s≥3.42 log10
      Alcohol-based sanitizers (60.5% alcohol w/w)10 s≥3.25 log10
      Alcohol-based sanitizers (65% alcohol w/w)10 s≥4.01 log10
      Alcohol-based sanitizers (95% alcohol w/w)15 s≥4.01 log10
      11Rabenau et al. (2005)SARS-CoVSterillium (45% iso-propanol, 30% n-propanol and 0.2% mecetronium etilsulphate)ST30 s≥4.25 log10Hands
      Sterillium rub (80% ethanol)≥4.25 log10
      {Gopal, 2020 #204}≥5.5 log10
      Sterillium Virugard (95% ethanol)≥5.5 log10
      12Hirose et al. (2020)IAV80% EA (ethanol)ST and HSST (5 s, 15 s and 60 s)/HS (5 s, 15 s and 60 s)ST (>4.10, >4.11, >4.07 log)/HS (>4.12, >4.16, >4.16 log)Skin
      60% EAST (>4.10, >4.11, >4.07 log)/HS (>4.12, >4.16, >4.16 log)
      40% EAST (>4.10, >4.11, >4.07 log)/HS (>4.12, >4.16, >4.16 log)
      20% EAST (∼0.09, ∼0.07, ∼0.06 log)/HS (∼0.73, ∼0.85, ∼0.88 log)
      70% IPA (isopropanol)ST (>4.10, >4.11, >4.07 log)/HS (>4.12, >4.16, >4.16 log)
      0.2% CHG (chlorhexidine gluconate)ST (∼0.08, ∼0.17, ∼0.19 log)/HS (∼0.74, ∼0.95, ∼1.02 log)
      1.0% CHGST (∼0.23, ∼0.24, ∼0.40 log)/HS (∼2.85, ∼3.25, ∼3.39 log)
      0.05% BAC (benzalkonium chloride)ST (∼0.69, ∼1.78, ∼2.71 log)/HS (∼0.78, ∼1.04, ∼1.23 log)
      0.2% BACST (∼2–43, ∼2.34, >4.07 log)/HS (∼1.64, ∼2.85, ∼3.24 log)
      SARS-CoV-280% EAST (>4.50, >4.50, >4.50 log)/HS (>4.19, >4.17, >4.14 log)
      60% EAST (>4.50, >4.50, >4.50 log)/HS (>4.19, >4.17, >4.14 log)
      40% EAST (>4.50, >4.50, >4.50 log)/HS (>4.19, >4.17, >4.14 log)
      20% EAST (∼0.08, ∼0.25, ∼0.33 log)/HS (∼0.53, ∼0.61, ∼0.81 log)
      70% IPAST (>4.50, >4.50, >4.50 log)/HS (>4.19, >4.17, >4.14 log)
      0.2% CHGST (∼0.33, ∼0.42, ∼0.58 log)/HS (∼2.19, ∼2.31, ∼2.42 log)
      1.0% CHGST (∼1.00, ∼1.42, ∼1.83 log)/HS (∼2.62, ∼2.94, ∼3.17 log)
      0.05% BACST (∼1.33, ∼1.75, ∼2.17 log)/HS (∼2.03, ∼2.19, ∼2.36 log)
      0.2% BACST (∼1.83, ∼2.42, ∼3.00 log)/HS (∼2.72, ∼2.97, ∼3.19 log)
      13Huang et al. (2020)Patients with SARS-CoV-2 infectionChlorhexidine oral rinse (15 mL)Oral and oropharyngeal cavity30 s twice a day for 4 days37.9% positive SARS-CoV-2 test, 62.1% negative testOral and oropharyngeal cavity
      without exposure(-)94.5% positive SARS-CoV-2 test, 5.5% negative test
      Chlorhexidine oral rinse (15 mL) + oropharyngeal spray (1.5 mL)30 s oral rinse + spray, twice a day for 4 days14.0% positive SARS-CoV-2 test, 80% negative test
      without exposure(-)93.8% positive SARS-CoV-2 test, 6.2% negative test
      14Ijaz et al. (2020)HCoV-229E (1), SARS-CoV-2 (2)Bar soap PCMX - (0.090% w/w)ST0.5–1 min(1) ≥3.3 log10, (2) ≥4.1 log10Hands
      Liquid gel handwash - salicylic acid (0.025% w/w)0.5–1 min(1) ≥3.6 log10, (2) ≥3.6 log10
      Foaming handwash - benzalkonium chloride (0.025% w/w)1 min(1) ≥3.3 log10, (2) ≥3.4 log10
      Foaming handwash - salicylic acid (0.023% w/w)0.5–1 min(1) ≥3.5 log10, (2) ≥5.0 log10
      Antiseptic liquid - PCMX (0.021% w/v)5 min(1) ≥5.2 log10, (2) ≥4.7 log10
      Hand sanitizer gel - ethanol (53% w/w)1 min(1) ≥5.4 log10, (2) ≥4.2 log10
      Hand sanitizer gel - citric acid (1.5% w/w), lactic acid (0.41% w/w)0.5–1 min(1) ≥5.2log10, (2) ≥4.7 log10
      15Steinhauer et al. (2020)Modified vaccinia virus Ankara20% hand disinfectant - propan-2-olST15 s∼0.17 log10Hands
      80% hand disinfectant - propan-2-ol15 s≥4.19 log10
      SARS-CoV-220% hand disinfectant - propan-2-ol15 s≥4.02 log10
      20% hand disinfectant - propan-2-ol30 s≥3.02 log10
      80% hand disinfectant - propan-2-ol15 s≥2.02 log10
      80% hand disinfectant - propan-2-ol30 s≥4.38 log10
      16Steinhauer et al. (2020)SARS-CoV-280% chlorhexidine bis-(D-gluconate) 0.1 gST5–10 min<1.00 log10Oral
      80% chlorhexidine bis-(D-gluconate) 0.2 g1–5 min<1.00 log10
      80% 0.1 g octenidine dihydrochloride, 2 g phenoxyethanol15 s≥4.00 log10
      80% 0.1 g octenidine dihydrochloride, 2 g phenoxyethanol30 s≥4.00 log10
      80% 0.1 g octenidine dihydrochloride, 2 g phenoxyethanol1 min≥4.00 log10
      20% 0.1 g octenidine dihydrochloride, 2 g phenoxyethanol15 s≥4.00 log10
      SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; MERS-CoV, Middle East respiratory syndrome coronavirus; HCoV, human coronavirus; PVP-I, povidone-iodine; WHO, World Health Organization; ST, suspension test; HS, human skin.
      Alcohols were mainly evaluated via suspension tests showing optimal virucidal activity (including SARS-CoV-2) at concentrations >65% and with exposure times of 15–60 s specifically for application to hands and the oral cavity [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Kratzel A.
      • Todt D.
      • V’Kovski P.
      • Steiner S.
      • Gultom M.
      • Thao T.T.N.
      • et al.
      Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
      ,
      • Rabenau H.F.
      • Kampf G.
      • Cinatl J.
      • Doerr H.W.
      Efficacy of various disinfectants against SARS coronavirus.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
      ,
      • Gudmundsdottir Á.
      • Scheving R.
      • Lindberg F.
      • Stefansson B.
      Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
      ,
      • Leslie R.A.
      • Zhou S.S.
      • Macinga D.R.
      Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers.
      ,
      • Meister T.L.
      • Brüggemann Y.
      • Todt D.
      • Conzelmann C.
      • Müller J.A.
      • Groß R.
      • et al.
      Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2.
      ,
      • Mukherjee S.
      • Vincent C.K.
      • Jayasekera H.W.
      • Yekhe A.S.
      Antiviral efficacy of personal care formulations against severe acute respiratory syndrome coronavirus 2.
      ,
      • Steinhauer K.
      • Meister T.L.
      • Todt D.
      • Krawczyk A.
      • Paßvogel L.
      • Becker B.
      • et al.
      Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2.
      ]. One study evaluated the efficacy of ethanol and propanol directly on human skin against SARS-CoV-2 and found that 40% concentrations of these alcohols can cause >4 log10 reduction in viral titre after just 5 s of exposure [
      • Hirose R.
      • Bandou R.
      • Ikegaya H.
      • Watanabe N.
      • Yoshida T.
      • Daidoji T.
      • et al.
      Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation.
      ]. Interestingly, WHO-recommended hand rub formulations containing 80% ethanol or propanol showed inferior efficacy compared with modified formulations (with 75% ethanol or propanol and half of the concentration of glycerol from the original formulation) when tested with SARS-CoV-2 [
      • Kratzel A.
      • Todt D.
      • V’Kovski P.
      • Steiner S.
      • Gultom M.
      • Thao T.T.N.
      • et al.
      Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
      ]. Soap bars evaluated in two studies were shown to reduce the quantity of SARS-CoV-2 significantly, with optimal results seen with a contact time of 20 s to 1 min [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Mukherjee S.
      • Vincent C.K.
      • Jayasekera H.W.
      • Yekhe A.S.
      Antiviral efficacy of personal care formulations against severe acute respiratory syndrome coronavirus 2.
      ]. QACs, specifically benzalkonium chloride 0.2%, can produce maximum virucidal activity after 60 s of exposure, verified in suspension tests and on human skin [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ,
      • Hirose R.
      • Bandou R.
      • Ikegaya H.
      • Watanabe N.
      • Yoshida T.
      • Daidoji T.
      • et al.
      Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation.
      ]. Liquids containing chloroxylenol, citric acid, lactic acid or salicylic acid were also effective in reducing coronavirus titres, including SARS-CoV-2 [
      • Ijaz M.K.
      • Nims R.W.
      • Zhou S.S.
      • Whitehead K.
      • Srinivasan V.
      • Kapes T.
      • et al.
      Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
      ].
      Oral rinses containing PVP-I 1–3% lead to >4.33 log10 reduction of SARS-CoV-2, MERS-CoV and modified vaccinia virus Ankara titres after 15–30 s of contact time [
      • Eggers M.
      • Eickmann M.
      • Zorn J.
      Rapid and effective virucidal activity of povidone-iodine products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA).
      ,
      • Bidra A.S.
      • Pelletier J.S.
      • Westover J.B.
      • Frank S.
      • Brown S.M.
      • Tessema B.
      Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses.
      ,
      • Bidra A.S.
      • Pelletier J.S.
      • Westover J.B.
      • Frank S.
      • Brown S.M.
      • Tessema B.
      Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse.
      ,
      • Meister T.L.
      • Brüggemann Y.
      • Todt D.
      • Conzelmann C.
      • Müller J.A.
      • Groß R.
      • et al.
      Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2.
      ]. The action of hydrogen peroxide oral rinses, on the other hand, is inferior to PVP-I [
      • Bidra A.S.
      • Pelletier J.S.
      • Westover J.B.
      • Frank S.
      • Brown S.M.
      • Tessema B.
      Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses.
      ]. Chlorhexidine gluconate (oral and skin formulations) seems to provide suboptimal virucidal activity compared with other agents in in-vitro suspension test experiments. However, a prospective cohort study on patients who were initially admitted to hospital with a positive SARS-CoV-2 test indicated that the application of chlorhexidine gluconate mouthwash and nasopharyngeal spray of the same agent can accelerate the clearance of SARS-CoV-2 in these areas, resulting in a negative reverse transcriptase polymerase chain reaction test after 4 days [
      • Huang Y.H.
      • Huang J.T.
      Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients.
      ]. Other antiseptic oral rinses containing chloride and benzalkonium or ethanol have also been shown to deactivate SARS-CoV-2 [
      • Gudmundsdottir Á.
      • Scheving R.
      • Lindberg F.
      • Stefansson B.
      Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
      ,
      • Meister T.L.
      • Brüggemann Y.
      • Todt D.
      • Conzelmann C.
      • Müller J.A.
      • Groß R.
      • et al.
      Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2.
      ].
      PVP-I can also be applied topically on eyes as an additional pre-procedure disinfection as concentrations of 0.9% can reduce SARS-CoV-2 titre significantly after 30 s of exposure [
      • Liang B.
      • Yuan X.
      • Wei G.
      • Wang W.
      • Zhang M.
      • Peng H.
      • et al.
      In-vivo toxicity studies and in-vitro inactivation of SARS-CoV-2 by povidone-iodine in-situ gel forming formulations.
      ]. On the other hand, a toxicity study carried out in rabbits revealed that groups exposed to ocular PVP-I 0.6% and 1.0% every day for 7 days showed signs of mild and transient ocular irritation [
      • Liang B.
      • Yuan X.
      • Wei G.
      • Wang W.
      • Zhang M.
      • Peng H.
      • et al.
      In-vivo toxicity studies and in-vitro inactivation of SARS-CoV-2 by povidone-iodine in-situ gel forming formulations.
      ]. Nasal cavity formulations consisting of PVP-I 0.54–5% are able to cause >3 log10 reduction in SARS-CoV-2 titre after 15 s of exposure [
      • Frank S.
      • Capriotti J.
      • Brown S.M.
      • Tessema B.
      Povidone-iodine use in Sinonasal and oral cavities: a review of safety in the COVID-19 era.
      ].

      Disinfection methods against airborne viruses

      Regarding disinfection methods against airborne coronaviruses, four articles were identified (Table IV) [
      • He H.
      • Dong X.
      • Yang M.
      • Yang Q.
      • Duan S.
      • Yu Y.
      • et al.
      Catalytic inactivation of SARS coronavirus, Escherichia coli and yeast on solid surface.
      ,
      • Buonanno M.
      • Welch D.
      • Shuryak I.
      • Brenner D.J.
      Far-UVC light (222nm)efficiently and safely inactivates airborne human coronaviruses.
      ,
      • Qiao Y.
      • Yang M.
      • Marabella I.A.
      • McGee D.A.J.
      • Aboubakr H.
      • Goyal S.
      • et al.
      Greater than 3-log reduction in viable coronavirus aerosol concentration in ducted ultraviolet-C (UV-C) systems.
      ,
      • Yu L.
      • Peel G.K.
      • Cheema F.H.
      • Lawrence W.S.
      • Bukreyeva N.
      • Jinks C.W.
      • et al.
      Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.
      ]. Wafers containing silver and copper combined with aluminium oxide display catalytic properties and can be incorporated in air conditioning systems to trap and kill viruses. These wafers are active against coronaviruses and can cause complete viral inactivation after 5 min of exposure [
      • He H.
      • Dong X.
      • Yang M.
      • Yang Q.
      • Duan S.
      • Yu Y.
      • et al.
      Catalytic inactivation of SARS coronavirus, Escherichia coli and yeast on solid surface.
      ].
      Table IVResults of disinfection methods against airborne viruses
      StudyVirusDisinfectantDisinfection phaseExposure timeReduction of viral infectivity (log10) or (%)
      1Buonanno et al. (2020)Alphacoronavirus HCoV-229EFar-UV-C light at 222 nm (0.5, 1 and 2 mJ/cm2)Dynamic aerosol/virus irradiation chamber∼20 s1.7 mJ/cm2 produce 99.9% inactivation (3-log reduction) of aerosolized alpha HCoV-229E
      Betacoronavirus HCoV-OC431.2 mJ/cm2 produce 99.9% inactivation (3-log reduction) of aerosolized beta HCoV-OC43
      2Qiao et al. (2020)PRCVUV-C light 200–850 nm (13.9 mJ/cm2)Wind tunnel (high flow rate of 2439 L/min)1.3 s2.2 log10 (99.4% removal efficiency)
      UV-C light 253±1 nm (49.6 mJ/cm2)Wind tunnel (low flow rate of 684 L/min)5.1 s3.7 log10 (99.98% removal efficiency)
      3Yu et al. (2020)SARS-CoV-2Novel Ni-foam-based filter (up to 200°C)Aerosolized SARS-CoV-2Single pass99.8% reduction
      4He et al. (2004)SARS coronavirusAg/Al2O3 (Ag 5 wt%) catalytic oxidationAg/Al2O3 and Cu/Al2O3 wafers5 min and 20 minVirus undetectable
      Cu/Al2O3 (Cu 10 wt%) catalytic oxidationVirus undetectable
      SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; PRCV, porcine respiratory coronavirus; HCoV, human coronavirus; UV-C, ultraviolet C irradiation; Ni, nickel; Ag, silver; Cu, copper.
      UV-C can efficiently inactivate up to 99.9% of aerosolized coronaviruses [
      • Buonanno M.
      • Welch D.
      • Shuryak I.
      • Brenner D.J.
      Far-UVC light (222nm)efficiently and safely inactivates airborne human coronaviruses.
      ]. Ventilation systems fitted with a UV-C light source that can control its flow rate, control the exposure time of air passage indirectly, as lower flow rates translate into longer exposure times which results in superior viral removal efficacy [
      • Qiao Y.
      • Yang M.
      • Marabella I.A.
      • McGee D.A.J.
      • Aboubakr H.
      • Goyal S.
      • et al.
      Greater than 3-log reduction in viable coronavirus aerosol concentration in ducted ultraviolet-C (UV-C) systems.
      ]. As all human coronaviruses have similar genomic size, a key determinant of radiation sensitivity, it is likely that UV-C irradiation will show comparable inactivation efficiency against other human coronaviruses, including SARS-CoV-2 [
      • Buonanno M.
      • Welch D.
      • Shuryak I.
      • Brenner D.J.
      Far-UVC light (222nm)efficiently and safely inactivates airborne human coronaviruses.
      ].

      Methods to decontaminate and recondition personal protective equipment

      Methods with potential use to decontaminate and recondition PPE were examined by 16 studies (Table V) [
      • Uppal T.
      • Khazaieli A.
      • Snijders A.M.
      • Verma S.C.
      Inactivation of human coronavirus by FATHHOME's dry sanitizer device: rapid and eco-friendly ozone-based disinfection of SARS-CoV-2.
      ,
      • Blanchard E.L.
      • Lawrence J.D.
      • Noble J.A.
      • Xu M.
      • Joo T.
      • Ng N.L.
      • et al.
      Enveloped virus inactivation on personal protective equipment by exposure to ozone.
      ,
      • Campos R.K.
      • Jin J.
      • Rafael G.H.
      • Zhao M.
      • Liao L.
      • Simmons G.
      • et al.
      Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities.
      ,
      • Choi Y.W.
      • Richardson A.W.
      • Sunderman M.
      • Mladineo M.J.
      • Keyes P.H.
      • Hofacre K.C.
      • et al.
      Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators (FFRs) with moist heat generated by a multicooker.
      ,
      • Daeschler S.C.
      • Manson N.
      • Joachim K.
      • Chin A.W.H.
      • Chan K.
      • Chen P.Z.
      • et al.
      Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function.
      ,
      • Gopal V.
      • Nilsson-Payant B.E.
      • French H.
      • Siegers J.Y.
      • Yung W.S.
      • Hardwick M.
      • et al.
      Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus.
      ,
      • Ibanez-Cervantes G.
      • Bravata-Alcantara J.C.
      • Najera-Cortes A.S.
      • Meneses-Cruz S.
      • Delgado-Balbuena L.
      • Cruz-Cruz C.
      • et al.
      Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices.
      ,
      • Ludwig-Begall L.F.
      • Wielick C.
      • Dams L.
      • Nauwynck H.
      • Demeuldre P.F.
      • Napp A.
      • et al.
      The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus.
      ,
      • Ma Q.X.
      • Shan H.
      • Zhang C.M.
      • Zhang H.L.
      • Li G.M.
      • Yang R.M.
      • et al.
      Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports.
      ,
      • Mantlo E.
      • Rhodes T.
      • Boutros J.
      • Patterson-Fortin L.
      • Evans A.
      • Paessler S.
      In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation.
      ,
      • Ozog D.M.
      • Sexton J.Z.
      • Narla S.
      • Pretto-Kernahan C.D.
      • Mirabelli C.
      • Lim H.W.
      • et al.
      The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2.
      ,
      • Perkins D.J.
      • Nofchissey R.A.
      • Ye C.
      • Donart N.
      • Kell A.
      • Foo-Hurwitz I.
      • et al.
      COVID-19 global pandemic planning: dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV-2 on N95 respirators.
      ,
      • Rathnasinghe R.
      • Karlicek R.F.
      • Schotsaert M.
      • Koffas M.A.
      • Arduini B.
      • Jangra S.
      • et al.
      Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device.
      ,
      • Rockey N.
      • Arts P.J.
      • Li L.
      • Harrison K.R.
      • Langenfeld K.
      • Fitzsimmons W.J.
      • et al.
      Humidity and deposition solution play a critical role in virus inactivation by heat treatment of N95 respirators.
      ,
      • Glasbrenner D.C.
      • Choi Y.W.
      • Richardson A.W.
      • Edwards E.W.
      • Mladineo M.J.
      • Sunderman M.
      • et al.
      Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators using artificial sun lamps.
      ,
      • Valdez-Salas B.
      • Beltran-Partida E.
      • Cheng N.
      • Salvador-Carlos J.
      • Valdez-Salas E.A.
      • Curiel-Alvarez M.
      • et al.
      Promotion of surgical masks antimicrobial activity by disinfection and impregnation with disinfectant silver nanoparticles.
      ]. Most of these studies investigated filtering facepiece respirators (FFRs), especially 3M N95 masks. Heat (70–95ºC) combined with different levels of relative humidity is capable of inactivating enveloped viruses, including SARS-CoV-2, inoculated on N95 level melt-blown polypropylene fabric after at least 20 min of exposure [
      • Campos R.K.
      • Jin J.
      • Rafael G.H.
      • Zhao M.
      • Liao L.
      • Simmons G.
      • et al.
      Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities.
      ,
      • Ma Q.X.
      • Shan H.
      • Zhang C.M.
      • Zhang H.L.
      • Li G.M.
      • Yang R.M.
      • et al.
      Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports.
      ,
      • Rockey N.
      • Arts P.J.
      • Li L.
      • Harrison K.R.
      • Langenfeld K.
      • Fitzsimmons W.J.
      • et al.
      Humidity and deposition solution play a critical role in virus inactivation by heat treatment of N95 respirators.
      ]. Filtration efficacy was maintained after several cycles. However, cycles should be limited to avoid compromising mask function. A limit of 20 disinfection cycles is suggested for treatments under high relative humidity (100%) and temperatures ≤85°C. Treatment should also be limited to five cycles under high relative humidity (100%) and temperatures ≤95°C [
      • Campos R.K.
      • Jin J.
      • Rafael G.H.
      • Zhao M.
      • Liao L.
      • Simmons G.
      • et al.
      Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities.
      ,
      • Choi Y.W.
      • Richardson A.W.
      • Sunderman M.
      • Mladineo M.J.
      • Keyes P.H.
      • Hofacre K.C.
      • et al.
      Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators (FFRs) with moist heat generated by a multicooker.
      ,
      • Daeschler S.C.
      • Manson N.
      • Joachim K.
      • Chin A.W.H.
      • Chan K.
      • Chen P.Z.
      • et al.
      Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function.
      ,
      • Ludwig-Begall L.F.
      • Wielick C.
      • Dams L.
      • Nauwynck H.
      • Demeuldre P.F.
      • Napp A.
      • et al.
      The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus.
      ]. Caution must be taken when a dry oven is utilized to generate dry heat (0% relative humidity) as samples placed on parchment paper prior to heating can result in lower efficacy of viral inactivation [
      • Perkins D.J.
      • Nofchissey R.A.
      • Ye C.
      • Donart N.
      • Kell A.
      • Foo-Hurwitz I.
      • et al.
      COVID-19 global pandemic planning: dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV-2 on N95 respirators.
      ].
      Table VResults of methods to recondition personal protective equipment
      StudyVirusDisinfectantDisinfection phaseExposure timeReduction of viral infectivity (log10) or (%)Effect on material properties and functionality
      1Blanchard et al. (2020)IAV and RSVOzone (20 ppm) + 50–70% RHSurgical facemasks (1 cm x 1 cm sample swatches)40 minEqual to 70% ethanol inactivationMaterial properties were preserved and filtration capacity of masks was maintained.
      Tyvek (disposable gown) 1 cm x 1 cm
      N95 respirators 1 cm x 1 cm
      Bunny suits 1 cm x 1 cm
      PAPR hoods 1 cm x 1 cm
      2Campos et al. (2020)SARS-CoV-2Ambient humidity (60%) without BSAMeltblown fabric from N95-grade FFRs60°C for 30 min2.16 ± 0.23 log10Temperatures of 75–85 °C are able to efficiently inactivate the virus in 20–30 min under 100% RH, without lowering filtration efficiency. Filtration efficacy started to decrease significantly after 10 cycles with temperature of 95°C probably due to the absorption of water or other mechanisms that can decay the electrostatic charge.
      Ambient humidity (60%) without BSA75°C for 30 min3.69 ± 0.32 log10
      Ambient humidity (60%) without BSA85°C for 20 min>4.77 log10
      Ambient humidity (60%) without BSA95°C for 5 min>4.77 log10
      Ambient humidity (60%) with BSA60°C for 30 min1.07 ± 0.06 log10
      Ambient humidity (60%) with BSA75°C for 30 min2.89 ± 0.31 log10
      Ambient humidity (60%) with BSA85°C for 20 min4.3 ± 0.55 log10
      Ambient humidity (60%) with BSA95°C for 5 min4.8 ± 0.44 log10
      100% humidity without BSA60°C for 30 min2.82 ± 0.09 log10
      100% humidity without BSA75°C for 30 min>4.97 log10
      100% humidity without BSA85°C for 20 min>4.97 log10
      100% humidity without BSA95°C for 5 min>4.97 log10
      100% humidity with BSA60°C for 30 min2.27 ± 0.09 log10
      100% humidity with BSA75°C for 30 min4.92 ± 0.12 log10
      100% humidity with BSA85°C for 20 min>5.02 log10
      100% humidity with BSA95°C for 5 min>5.02 log10
      3Choi et al. (2020)SARS-CoV-2Moist heat generated by multi-cookerFFRs 3M Model 1860 in simulated saliva65°C for 30 min∼1.5 log10All FFRs absorbed <1 g of water when in a paper bag. Collection efficacy exceeded 95% and inhalation resistance was preserved. After five cycles of moist heat treatment, 3M 8210 and NS 721 had no change in strap elasticity, while 3M 1860 and 3M 8511 showed a small change (<10%).
      FFRs 3M Model 1860 in simulated lung fluid∼3.2 log10
      FFRs 3M Model 8511 in simulated saliva∼2.5 log10
      FFRs 3M Model 8511 in simulated lung fluid∼3.2 log10
      FFRs 3M Model 8210 in simulated saliva∼2.2 log10
      FFRs NS Model 7210 in simulated saliva∼2.2 log10
      4Daeschler et al. (2020)SARS-Cov-270°C + 50% RHN95 respirators2–18 minReduced to undetectable levelsMasks maintained fibre diameters similar to untreated masks and continued to meet standards for fit, filtration efficiency and breathing resistance.
      5Gopal et al. (2020)SARS-Cov-2Zinc oxide embedded into fabrics (only tested on PA66)Cotton, polypropylene (PPP) fabrics and polyamide (PA66)60 min2 logCotton and polyamide 66 (PA66) can strongly trap viruses as only 56% of SARS-CoV-2 can be recovered from cotton samples and 92% from PA66 after viral inoculation. PPP is poor at trapping viruses.
      6Ibanez-Cervantes et al. (2020)SARS-CoV-2Hydrogen peroxide plasmaN95 3M Model 821047 minUndetectable by RT-PCRNot tested
      7Ludwig-Begall et al. (2020)PRCVUV irradiationSurgical mask coupons2 min∼5 log10Not tested
      Vaporized H2O2 (59% liquid H2O2) 750 ppm28 min∼5 log10
      Dry heat (102°C)60 min∼5.5 log10
      UV irradiationSurgical mask straps2 min∼2.9 log10
      Vaporized H2O2 (59% liquid H2O2) 750 ppm28 minNon-significant
      Dry heat (102°C)60 min∼1.2 log10
      UV irradiationFFR coupons4 min∼3.2 log10
      Vaporized H2O2 (59% liquid H2O2) 750 ppm28 min∼4 log10
      Dry heat (102°C)60 min∼2.5 log10
      UV irradiationFFR straps4 min(-)
      Vaporized H2O2 (59% liquid H2O2) 750 ppm28 min∼1.2 log10
      Dry heat (102°C)60 min(-)
      8Ma et al. (2020)Avian infectious bronchitis virusSteamN95 FFR masks5 minUndetectable by RT-PCRBlocking efficacy of 99% verified in all masks except for one model that seemed to have thinner layers compared with other models. Therefore, masks with thinner layers can have reduced blocking efficacy.
      9Mantlo et al. (2020)SARS-CoV-2Clyraguard copper iodine complex undilutedSuspension test10 min2 logNot tested
      30 minBelow limit of detection (<75 TCID50 per mL)
      60 minBelow limit of detection (<75 TCID50 per mL)
      10Ozog et al. (2020)SARS-CoV-2UV-C irradiation (1.5 J/cm2 to each side)N95 FFR models (3M 1860, 8210, 8511, 9211; Moldex 1511)60–70 s (for each side)Below limit of detection (101.3 TCID50/4 mm punch)Not tested
      11Perkins et al. (2020)SARS-CoV-2Dry heat (60°C)N95 respirator coupons + parchment paper60 minAll samples were positive analysed by microscopy for cytopathic effectNot tested
      Dry heat (70°C)60 minAll samples were positive analysed by microscopy for cytopathic effect
      Dry heat (75°C)60 minAll samples were positive analysed by microscopy for cytopathic effect
      Dry heat (60°C)N95 respirator coupons + tissue culture(-)(-)
      Dry heat (70°C)60 minAll samples were positive analysed by microscopy for cytopathic effect
      Dry heat (75°C)60 minAll samples were positive analysed by microscopy for cytopathic effect
      Dry heat (60°C)Intact N95 respirators(-)(-)
      Dry heat (70°C)60 minAll samples were positive analysed by microscopy for cytopathic effect
      Dry heat (75°C)60 minMost samples were positive analysed by microscopy for cytopathic effect
      Ambient temperature5 days5/9 samples were positive analysed by microscopy for cytopathic effect
      12Rathnasinghe et al. (2020)SARS-CoV-2UV-C irradiation (5.43 mW/cm2)N95 mask squares120 s per side3.5 logNot tested
      13Rockey et al. (2020)Bacteriophage MS2Temperature (72°C and 82°C) + PBSN95 respirator coupons30 min0.24 log 10 (72°C + 1% RH), 0.19 log10 (82°C + 1% RH)Not tested
      6.87 log 10 (72°C + 89% RH), 6,90 log10 (82°C + 89% RH)
      Temperature (72°C and 82°C) + DMEM-A1.44 log 10 (72°C + 1% RH), 2.77 log10 (82°C + 1% RH)
      6.56 log 10 (72°C + 89% RH), 7.16 log10 (82°C + 89% RH)
      Temperature (72°C and 82°C) + saliva0.99 log 10 (72°C + 13% RH), 0.88 log10 (82°C + 1% RH)
      1.45 log 10 (72°C + 25% RH), 1.74 log10 (82°C + 13% RH)
      Temperature (72°C and 82°C) + (PBS + BSA)1.5 log 10 (72°C + 13% RH), 0.77 log10 (82°C + 1% RH)
      2.72 log 10 (72°C + 25% RH), 3.56 log10 (82°C + 13% RH)
      Bacteriophage phi6Temperature (72°C and 82°C) + PBS0.99 log 10 (72°C + 1% RH), 1.48 log10 (82°C + 1% RH)
      6.79 log 10 (72°C + 89% RH), 6,70 log10 (82°C + 89% RH)
      Temperature (72°C and 82°C) + DMEM-A2.58 log 10 (72°C + 1% RH), 3.87 log10 (82°C + 1% RH)
      6.81 log 10 (72°C + 89% RH), 7.63 log10 (82°C + 89% RH)
      Temperature (72°C and 82°C) + saliva0.95 log 10 (72°C + 13% RH), 1.09 log10 (82°C + 1% RH)
      1.69 log 10 (72°C + 25% RH), 2.62 log10 (82°C + 13% RH)
      Temperature (72°C and 82°C) + (PBS + BSA)1.33 log 10 (72°C + 13% RH), 0.76 log10 (82°C + 1% RH)
      1.34 log 10 (72°C + 25% RH), 1.98 log10 (82°C + 13% RH)
      MHVTemperature (72°C and 82°C) + DMEM-A2.51 log 10 (72°C + 1% RH), 3.30 log10 (82°C + 1% RH)
      4.19 log 10 (72°C + 89% RH), 4.38 log10 (82°C + 89% RH)
      IAVTemperature (72°C and 82°C) + DMEM-A1.25 log 10 (72°C + 1% RH), 2.71 log10 (82°C + 1% RH)
      3.71 log 10 (72°C + 89% RH), 3.37 log10 (82°C + 89% RH)
      14Glasbrenner et al. (2021)TGEVUV (300–400 nm) simulated sunlightFFR 3M 1860(-)(-)All FFRs maintained collection efficacy and breathing resistance after one and five cycles ((Model 3M 8210 not tested for five cycles). Reduced strap elasticity from NS 7210 model with 19% change in stress).
      FFR 3M 8210(-)(-)
      FFR 3M 8511(-)Inactivation less efficient
      FFR NS 7210(-)Inactivation below level of detection
      SARS-CoV-2FFR 3M 1860 + SS and LF20 min (13.3 J cm2) SS/40 min (26.5 J cm2) FLInactivation below level of detection
      FFR 3M 8210 + SS and LF(-)(-)
      FFR 3M 8511 + SS and LF60 min (37.8 J cm2) for SS and FLComplete inactivation
      FFR NS 7210 + SS and LF20 min (13.3 J cm2) for SS and LFInactivation below level of detection
      15Uppal et al. (2021)HCoV-OC43Ozone (20 ppm)N95 FFRs10 min98.1411%Not tested
      Ozone (25 ppm)10 min97.4138%
      15 min99.9947%
      20 min99.9966%
      Ozone (50 ppm)10 min99.9860%
      15 min99.9956%
      20 min99.9925%
      16Valdez-Salas et al. (2021)Enveloped H5N1 avian influenza virusFormulated disinfectant - 0.2% benzalkonium chloride, 85% ethanol-water, 0.03% triclosan, 10% silver nanoparticles, 0.3% lauryl alcohol ethoxylate, 0.2% Triton X-100, 2% citric acid, microdacynSuspension test15 minNo presence of haemagglutinine - complete inactivationNot tested
      IAV, avian influenza virus; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; PRCV, porcine respiratory coronavirus; IBV, avian infectious bronchitis virus; MHV, mouse hepatitis coronavirus; PAPR, powered air purifying respirator; FFR, filtering facepiece respirator; RH, relative humidity; UV-C, ultraviolet C irradiation; PSB, phosphate-buffered saline; BSA, bovine serum albumin; DMEM, Dulbecco's modified Eagle medium; SS, simulated saliva; FF, lung fluid.
      Other than heat treatment, face masks made with cloth fabric, disposable gowns and powered air purifying respirator hoods can all be decontaminated successfully with doses of at least 20 ppm of ozone [
      • Blanchard E.L.
      • Lawrence J.D.
      • Noble J.A.
      • Xu M.
      • Joo T.
      • Ng N.L.
      • et al.
      Enveloped virus inactivation on personal protective equipment by exposure to ozone.
      ]. N95 respirators inoculated with HCoV were also adequately decontaminated after 10–20 min of exposure to 20–50 ppm ozone gas [
      • Uppal T.
      • Khazaieli A.
      • Snijders A.M.
      • Verma S.C.
      Inactivation of human coronavirus by FATHHOME's dry sanitizer device: rapid and eco-friendly ozone-based disinfection of SARS-CoV-2.
      ].
      Metals such as copper and zinc possess antiviral activity. Zinc ions incorporated in fabrics, such as cotton and polyamide 66 (PA66), can inactivate SARS-CoV-2 while maintaining virucidal activity after 50 washes, supporting the possibility of long-lasting virucidal protection [
      • Gopal V.
      • Nilsson-Payant B.E.
      • French H.
      • Siegers J.Y.
      • Yung W.S.
      • Hardwick M.
      • et al.
      Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus.
      ]. It is worth noting that cotton and PA66 can trap viruses, as only 56% and 92% of SARS-CoV-2 can be recovered from cotton samples and PA66, respectively, after viral inoculation. This information is relevant as cotton- and PA66-based masks can trap large amounts of SARS-CoV-2, making cross-contamination more probable when masks are reused without decontamination [
      • Gopal V.
      • Nilsson-Payant B.E.
      • French H.
      • Siegers J.Y.
      • Yung W.S.
      • Hardwick M.
      • et al.
      Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus.
      ]. Copper iodine complex has the potential to be used on non-critical PPE as it has been shown to completely deactivate SARS-CoV-2 in suspension after 30 min of exposure [
      • Mantlo E.
      • Rhodes T.
      • Boutros J.
      • Patterson-Fortin L.
      • Evans A.
      • Paessler S.
      In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation.
      ]. An innovative formulation that consists of silver and antimicrobial substances (ethanol and QACs) has also been shown to possess antiviral activity when impregnated in the matrix of surgical masks [
      • Valdez-Salas B.
      • Beltran-Partida E.
      • Cheng N.
      • Salvador-Carlos J.
      • Valdez-Salas E.A.
      • Curiel-Alvarez M.
      • et al.
      Promotion of surgical masks antimicrobial activity by disinfection and impregnation with disinfectant silver nanoparticles.
      ].
      Hydrogen peroxide vapour can also inactivate SARS-CoV-2 deposited on N95 masks and FFRs. This last process can be conducted in a STERRAD 100NX sterilization system or a V-PRO Max Sterilizer providing exposure cycles of ≤47 min [
      • Ibanez-Cervantes G.
      • Bravata-Alcantara J.C.
      • Najera-Cortes A.S.
      • Meneses-Cruz S.
      • Delgado-Balbuena L.
      • Cruz-Cruz C.
      • et al.
      Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices.
      ,
      • Ludwig-Begall L.F.
      • Wielick C.
      • Dams L.
      • Nauwynck H.
      • Demeuldre P.F.
      • Napp A.
      • et al.
      The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus.
      ].
      UV irradiation was able to inactivate coronaviruses deposited on surgical masks and FFRs [
      • Ludwig-Begall L.F.
      • Wielick C.
      • Dams L.
      • Nauwynck H.
      • Demeuldre P.F.
      • Napp A.
      • et al.
      The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus.
      ,
      • Ozog D.M.
      • Sexton J.Z.
      • Narla S.
      • Pretto-Kernahan C.D.
      • Mirabelli C.
      • Lim H.W.
      • et al.
      The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2.
      ,
      • Rathnasinghe R.
      • Karlicek R.F.
      • Schotsaert M.
      • Koffas M.A.
      • Arduini B.
      • Jangra S.
      • et al.
      Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device.
      ]. Exposure times needed to decontaminate these materials completely ranged from 60 s to 4 min when the models tested were N95 FFRs. It is worth noting that the efficacy of UV-C irradiation is model-dependent, and straps that contain hydrophilic properties seem to cause a lower reduction in viral titre [
      • Ozog D.M.
      • Sexton J.Z.
      • Narla S.
      • Pretto-Kernahan C.D.
      • Mirabelli C.
      • Lim H.W.
      • et al.
      The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2.
      ]. Exposure to simulated sunlight for 20 min, characterized by UV irradiation with wavelengths ranging between 300 and 400 nm, can reduce SARS-CoV-2 titre significantly on specific models of N95 masks [
      • Glasbrenner D.C.
      • Choi Y.W.
      • Richardson A.W.
      • Edwards E.W.
      • Mladineo M.J.
      • Sunderman M.
      • et al.
      Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators using artificial sun lamps.
      ].

      Risk of bias

      It was only possible to evaluate selection bias in two studies as the majority of experiments took place in in-vitro settings. Only one study blinded the personnel, so the other studies may contain performance bias. Thirteen studies were considered to have a probable risk of attrition or exclusion bias, eight studies had probable risk of detection bias, two studies had probable risk of selective reporting bias, and three studies had probable risk of potential threat to internal validity. A summary of the evaluation is provided in Table VI.
      Table VIRisk of bias assessment using the Office of Health Assessment and Translation (OHAT) Risk of Bias Rating Tool for Human and Animal Studies Potential source of bias was graded as low risk (++), probable low risk (+), probable high risk or not reported (−) and high risk (−−)
      StudyStudy designWas administered dose or exposure level adequately randomized?Was allocation to study groups adequately concealed?Were experimental conditions identical across study groups?Were research personnel blinded to the study group during the study?Were outcome data complete without attrition or exclusion from analysis?Can we be confident in the exposure characterization?Can we be confident in the outcome assessment (including blinding of assessors)?Were all measured outcomes reported?Were there no other potential threats to internal validity?
      Anderson et al. (2020)In vitroNot applicableNot applicable(++)(NR)(NR)(NR)(+)(++)(+)
      Bedell et al. (2016)In vitroNot applicableNot applicable(++)(-)(NR)(NR)(-)(++)(-)
      Behzadinasab et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Bidra et al. (2020)In vitroNot applicableNot applicable(++)(-)(NR)(++)(++)(++)(+)
      Bidra et al. (2020)In vitroNot applicableNot applicable(++)(-)(NR)(++)(++)(++)(+)
      Biryukov et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(+)(++)
      Blanchard et al. (2020)In vitroNot applicableNot applicable(-)(-)(NR)(++)(++)(+)(+)
      Buonanno et al. (2020)In vitroNot applicableNot applicable(++)(-)(NR)(++)(++)(++)(++)
      Campos et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Casanova et al. (2010)In vitroNot applicableNot applicable(+)(-)(++)(+)(++)(++)(++)
      Choi. et al. (2020)In vitroNot applicableNot applicable(+)(-)(++)(+)(++)(++)(+)
      Colnago et al. (2020)In vitroNot applicableNot applicable(++)(-)(-)(-)(++)(++)(+)
      Criscuolo et al. (2021)In vitroNot applicableNot applicable(++)(-)(+)(++)(+)(++)(+)
      Daeschler et al. (2020)In vitroNot applicableNot applicable(++)(+)(++)(++)(+)(++)(++)
      Eggers et al. (2015)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(++)(+)
      Frank et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(+)(++)(++)(+)
      Gamble et al. (2020)In vitroNot applicableNot applicable(+)(-)(+)(++)(++)(++)(+)
      Gerchman et al. (2020)In vitroNot applicableNot applicable(++)(-)(-)(++)(+)(++)(+)
      Gopal et al. (2020)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(++)(+)
      Gudmundsdottir et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(-)(++)(++)(+)
      He et al. (2004)In vitroNot applicableNot applicable(-)(-)(+)(++)(++)(-)(+)
      Heilingloh et al. (2020)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(+)(++)
      Hulkower et al. (2011)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Ibanez-Cervantes et al. (2020)In vitroNot applicableNot applicable(++)(-)(+)(+)(++)(++)(++)
      Khaiboullina et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(+)(++)
      Kratzel et al. (2020)In vitroNot applicableNot applicable(NR)(-)(++)(++)(++)(++)(++)
      Leslie et al. (2020)In vitroNot applicableNot applicable(NR)(-)(+)(+)(++)(+)(-)
      Liang et al. (2020)In vivo and in vitro(+)(NR)(++)(NR)(++)(++)(+)(++)(+)
      Liu et al. (2020)In vitroNot applicableNot applicable(+)(-)(+)(++)(+)(++)(+)
      Ludwig-Begall et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Ma et al. (2020)In vitroNot applicableNot applicable(-)(-)(NR)(+)(+)(++)(+)
      Malenovská (2020)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(++)(++)
      Mantlo et al. (2020)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(++)(++)
      Martins et al. (2020)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(+)(++)
      Meister et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(-)(++)(+)(+)
      Meyers et al. (2020)In vitroNot applicableNot applicable(++)(-)(-)(++)(++)(+)(-)
      Monge et al. (2020)In vitroNot applicableNot applicable(NR)(-)(+)(+)(+)(++)(+)
      Mukherjee et al. (2020)In vitroNot applicableNot applicable(+)(-)(+)(-)(+)(++)(+)
      Ozog et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Perkins et la (2020)In vitroNot applicableNot applicable(++)(-)(+)(-)(+)(++)(+)
      Qiao et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(+)
      Rabenau et al. (2005)In vitroNot applicableNot applicable(++)(-)(++)(++)(+)(+)(++)
      Rathnasinghe et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(+)(++)(++)
      Ratnesar-Shumate et al. (2020)In vitroNot applicableNot applicable(++)(+)(++)(++)(++)(++)(++)
      Rockey et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Wood and Payne (1998)In vitroNot applicableNot applicable(++)(-)(++)(++)(+)(+)(+)
      Yu et al. (2020)In vitroNot applicableNot applicable(NR)(-)(NR)(++)(+)(NR)(+)
      Franke et al. (2021)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Gidari et al. (2021)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Glasbrenner et al. (2021)In vitroNot applicableNot applicable(+)(-)(-)(-)(++)(+)(+)
      Hirose et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Hu et al. (2021)In vitroNot applicableNot applicable(++)(-)(+)(++)(++)(+)(+)
      Huang et al. (2020)Prospective cohort(++)(-)(-)(-)(++)(++)(++)(++)(+)
      Ijaz et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Messina et al. (2021)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Steinhauer et al. (2020)In vitroNot applicableNot applicable(+)(-)(+)(++)(++)(+)(+)
      Steinhauer et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Trivellin et al. (2020)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Uppal et al. (2021)In vitroNot applicableNot applicable(++)(-)(++)(++)(++)(++)(++)
      Valdez-Salas et al. (2021)In vitroNot applicableNot applicable(-)(-)(-)(++)(+)(+)(+)

      Discussion

      Stability and survival of SARS-CoV-2 exposed to heat and high humidity

      Under ambient conditions (temperatures of 21–23°C and relative humidity of 40%), SARS-CoV-2 can remain viable on surfaces for hours to days [
      • Johansson M.A.
      • Quandelacy T.M.
      • Kada S.
      • Prasad P.V.
      • Steele M.
      • Brooks J.T.
      • et al.
      SARS-CoV-2 transmission from people without COVID-19 symptoms.
      ,
      • Meyers C.
      • Kass R.
      • Goldenberg D.
      • Milici J.
      • Alam S.
      • Robison R.
      Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
      ]. The findings of this review support the evidence that coronaviruses are less viable when exposed to higher temperatures and higher relative humidity. It is not always possible to change the room temperature or humidity in indoor settings. However, rooms with the possibility to set these parameters between a determined range, such as intensive care units, operating rooms or hospital wards, can benefit as the survival of viruses is reduced markedly in warmer and higher humidity conditions.

      Disinfection methods on environmental surfaces

      Although most chemical agents have demonstrated virucidal activity against the coronavirus family, alcohols with concentrations of at least 60% showed a more constant and significant reduction in viral titres, promoting viral inactivation with shorter time exposures. This suggests that alcohols may be a better option when it comes to choosing a fast-acting and effective agent. Sodium hypochlorite, if preferred, should be used as a 0.1% solution, at least. If using QACs, a minimum exposure time of 30 min is recommended.
      As household dishwashing detergent is more accessible compared with the other coatings discussed, it can be an effective alternative in providing long-lasting virucidal protection on surfaces in household settings or in countries that have difficulty in accessing other products, such as alcohols. However, further investigation is still needed to determine the efficacy and practicality of these coatings.
      Ozone has virucidal activity targeting proteins on the viral envelope, inhibiting its entry to host cells. Higher concentrations of ozone must be used with caution due to the potential toxicity to humans; therefore, an ozone concentration of 20 ppm and an exposure time of 15 min is considered to be sufficient for optimal disinfection of surfaces [
      • Criscuolo E.
      • Diotti R.A.
      • Ferrarese R.
      • Alippi C.
      • Viscardi G.
      • Signorelli C.
      • et al.
      Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials.
      ,
      • Rojas-Valencia M.N.
      Research on ozone application as disinfectant and action mechanisms on wastewater microorganisms.
      ,
      • Nuvolone D.
      • Petri D.
      • Voller F.
      The effects of ozone on human health.
      ].
      For surface disinfection, UV-C irradiation seems to be the best alternative, as it is widely available and exceptionally convenient. It may be preferred over ozone as it is safer and less toxic to humans. However, when used with the purpose of whole-room disinfection, other methods, such as surface antimicrobial agents, could complement the strategy, as some surfaces may not be fully decontaminated due to shadowing or the composition of absorbable materials, such as fleece and wood.

      Disinfection methods on biological surfaces

      Adequate disinfection of hands is an important way to prevent indirect transmission of respiratory infections, especially during the era of SARS-CoV-2. Based on the review findings and evidence in the literature, the original formulations of WHO-recommended hand rubs seem to be less active against SARS-CoV-2 compared with modified formulations [
      • Kratzel A.
      • Todt D.
      • V’Kovski P.
      • Steiner S.
      • Gultom M.
      • Thao T.T.N.
      • et al.
      Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
      ,
      • Suchomel M.
      • Steinmann J.
      • Kampf G.
      Efficacies of the original and modified World Health Organization-recommended hand-rub formulations.
      ]. This is significant as many companies seek standard recommendations from WHO to produce disinfectants with the adequate proportion of ethanol/isopropanol and glycerol. These formulations could be updated to ensure optimal disinfection efficacy of formulations against SARS-CoV-2. Commercially available personal care products, such as soap bars, liquid cleansers (containing surfactant) and alcohol-based hand sanitizers (at least 30% ethanol or propanol), were all able to reduce SARS-CoV-2 titre after 10–20 s of exposure [
      • Kratzel A.
      • Todt D.
      • V’Kovski P.
      • Steiner S.
      • Gultom M.
      • Thao T.T.N.
      • et al.
      Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
      ,
      • Leslie R.A.
      • Zhou S.S.
      • Macinga D.R.
      Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers.
      ,
      • Mukherjee S.
      • Vincent C.K.
      • Jayasekera H.W.
      • Yekhe A.S.
      Antiviral efficacy of personal care formulations against severe acute respiratory syndrome coronavirus 2.
      ,
      • Rabenau H.F.
      • Cinatl J.
      • Morgenstern B.
      • Bauer G.
      • Preiser W.
      • Doerr H.W.
      Stability and inactivation of SARS coronavirus.
      ]. This suggests that the current procedure for handwashing is effective against SARS-CoV-2 at the established concentrations and duration.
      At present, no methods are in place regarding eye or respiratory tract disinfection in order to stop the transmission of SARS-CoV-2, and this deserves further investigation due to potential toxicity. However, there are viable options in specific settings, such as during ophthalmologic procedures or interventions where aerosols may be generated. While very low concentrations of PVP-I showed in-vitro viral inactivation, in-vivo conditions must be taken into account due to the fact that biological debris such as physiological buffers in nasal secretions can lower the effective concentration of PVP-I. Therefore, a concentration of at least 1.25% PVP-I is recommended for in-vivo application [
      • Frank S.
      • Brown S.M.
      • Capriotti J.A.
      • Westover J.B.
      • Pelletier J.S.
      • Tessema B.
      In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2.
      ].
      In summary, for oral rinses and skin cleansers, products containing PVP-I should be preferred, as its action is rapid and efficient. Soap bars, surfactant and alcohol-based hand sanitizers are all excellent alternatives for hand hygiene.

      Disinfection methods against airborne viruses

      Recent evidence indicates that airborne transfer is the main route of transmission of SARS-CoV-2, being more evident in indoor spaces with poor ventilation. Considering that coronaviruses cannot tolerate high temperatures, filtration or ventilation systems coupled with heatable metal filters may be an effective option. It is also evident that SARS-CoV-2 is susceptible to UV-C irradiation. As the latter is the only commercially available option at present, the installation of an upper room germicidal UV-C irradiation device, for example, in healthcare facilities, indoor spaces that accommodate a large number of people, or even in household settings, can be beneficial. Other than UV irradiation, the remaining methods in this section provide preliminary evidence of effective ways to decontaminate the air, indicating the future of more sophisticated and efficient air conditioning systems.

      Methods to decontaminate and recondition personal protective equipment

      The COVID-19 pandemic has had a significant impact on the environment and mass production of PPE to meet the world's rapid and urgent demand, creating major challenges in waste management on a global scale [
      • Binda G.
      • Bellasi A.
      • Spanu D.
      • Pozzi A.
      • Cavallo D.
      • Bettinetti R.
      Evaluating the environmental impacts of personal protective equipment use by the general population during the COVID-19 pandemic: a case study of Lombardy (Northern Italy).
      ,
      • Rizan C.
      • Reed M.
      • Bhutta M.F.
      Environmental impact of personal protective equipment distributed for use by health and social care services in England in the first six months of the COVID-19 pandemic.
      ,
      • Zhang E.J.
      • Aitchison L.P.
      • Phillips N.
      • Shaban R.Z.
      • Kam A.W.
      Protecting the environment from plastic PPE.
      ]. Surgical masks, for instance, are composed of plastic that is not biodegradable and may end up in waterbeds, causing harm to the environment and the fauna of these areas. Methods that aim to decontaminate and recondition PPE for reuse can be beneficial not only for the environment but also in cases of shortages of PPE, as experienced by many countries during the COVID-19 pandemic.
      Based on these studies, there is still insufficient evidence to support the virucidal efficacy of metal-embedded fabrics. Moreover, as it is important to preserve the functionality of PPE after decontamination, the only methods that provided evidence of effective sterilization without compromising the integrity of PPE (with a limited number of cycles) were heat and ozone treatment, making these methods better and safer options at the present time.

      Deposition solutions

      Three of the studies included in this review addressed how different deposition solutions can change the viral inactivation rate. It was found that the viral load of SARS-CoV-2 and bacteriophages MS2 and Phi6 deposited in DMEM-A (cell culture medium formulations) showed, under different temperature and humidity exposures, a more significant reduction in viral titre compared with the viral load deposited in phosphate-buffered saline (PBS) [
      • Meyers C.
      • Kass R.
      • Goldenberg D.
      • Milici J.
      • Alam S.
      • Robison R.
      Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
      ]. Interestingly, the viral load deposited in freshly collected human saliva demonstrated a log10 reduction trend more similar to PBS compared with DMEM-A. Bovine serum albumin containing higher concentrations of protein can be used to mimic body fluids, particularly sputum [
      • Anderson E.R.
      • Hughes G.L.
      • Patterson E.I.
      Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.
      ,
      • Ratnesar-Shumate S.
      • Williams G.
      • Green B.
      • Krause M.
      • Holland B.
      • Wood S.
      • et al.
      Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces.
      ]. This may suggest that laboratory-made solutions may not fully represent the behaviour of biological fluids.

      Limitations of this review

      One major limitation of this systematic review is that all the studies included are based on in-vitro findings, with some extensive experiments trying to mimic in-vivo conditions. However, the real efficacy in in-vivo settings needs further investigation.
      Nineteen of the studies included in this review used surrogate viruses to mimic the behaviour of SARS-CoV-2. Surrogate viruses were included due to the biosafety level of SARS-CoV-2 that may hinder the use of this virus in some experiments. It may also have been unavailable in some laboratories, especially at the beginning of the pandemic when little was known about SARS-CoV-2. To evaluate the efficacy of disinfectants, vaccinia virus, in particular, is a reference virus used in Europe as a surrogate for enveloped viruses (EN 14476) [
      • Eggers M.
      • Schwebke I.
      • Suchomel M.
      • Fotheringham V.
      • Gebel J.
      • Meyer B.
      • et al.
      The European tiered approach for virucidal efficacy testing – rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases.
      ]. As SARS-CoV-2 is an enveloped virus easily susceptible to disinfection, as verified in the review findings, methods that can effectively target more resilient surrogate enveloped viruses translate into efficacy against SARS-CoV-2.
      In conclusion, the results demonstrate that several household and hospital disinfection agents, UV-C irradiation, ozone and surface coatings are effective for inactivation of the coronavirus family, including SARS-CoV-2, on environmental surfaces. While SARS-CoV-2 can survive for hours to days depending on the surface, high temperature and humidity are key factors in viral decay. Decontamination of PPE can be performed effectively using heat treatment, UV-C irradiation and hydrogen peroxide vapour. Zinc ions can potentially provide prolonged disinfection when embedded into fabrics. Formulations containing PVP-I at different concentrations can provide virucidal action in the form of oral rinses, topical eye disinfection and skin cleansers. In the case of hand hygiene, typical soap bars, ethanol and propanol can inactivate SARS-CoV-2. Regarding disinfection methods against airborne particles, air filtration systems with materials that possess catalytic properties, UV-C devices and heating systems can reduce viral particles effectively. This review supports improved selection of the most effective disinfection method for each specific setting, potentially resulting in better outcomes during the present pandemic, and also the prevention of viral healthcare-associated infections.

      Acknowledgements

      The first author wishes to thank Dr. Luís Cobrado for his expertise and guidance throughout this work, and Carolina Xavier for support, effort and assistance regarding the writing and language of this work.

      Appendix A. Supplementary data

      The following is the Supplementary data to this article:

      Conflicts of interest statement

      None declared.

      Funding sources

      None.

      References

        • Mofijur M.
        • Fattah I.M.R.
        • Alam M.A.
        • Islam A.B.M.S.
        • Ong H.C.
        • Rahman S.M.A.
        • et al.
        Impact of COVID-19 on the social, economic, environmental and energy domains: lessons learnt from a global pandemic.
        Sustain Prod Consum. 2021; 26: 343-359
        • World Health Organization
        COVID-19 weekly epidemiological update.
        WHO, Geneva2021
        • Lu R.
        • Zhao X.
        • Li J.
        • Niu P.
        • Yang B.
        • Wu H.
        • et al.
        Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
        Lancet. 2020; 395: 565-574
        • Centers for Disease Control and Prevention
        Scientific brief: SARS-CoV-2 transmission.
        CDC, Atlanta, GA2021
        • Bulfone T.C.
        • Malekinejad M.
        • Rutherford G.W.
        • Razani N.
        Outdoor transmission of SARS-CoV-2 and other respiratory viruses: a systematic review.
        J Infect Dis. 2021; 223: 550-561
        • Greenhalgh T.
        • Jimenez J.L.
        • Prather K.A.
        • Tufekci Z.
        • Fisman D.
        • Schooley R.
        Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
        Lancet. 2021; 397: 1603-1605
        • Johansson M.A.
        • Quandelacy T.M.
        • Kada S.
        • Prasad P.V.
        • Steele M.
        • Brooks J.T.
        • et al.
        SARS-CoV-2 transmission from people without COVID-19 symptoms.
        JAMA Network Open. 2021; 4: e2035057
        • Lewis D.
        Superspreading drives the COVID pandemic – and could help to tame it.
        Nature. 2021; 590: 544-546
        • World Health Organization
        Transmission of SARS-CoV-2: implications for infection prevention precautions.
        WHO, Geneva2020
        • van Doremalen N.
        • Bushmaker T.
        • Morris D.H.
        • Holbrook M.G.
        • Gamble A.
        • Williamson B.N.
        • et al.
        Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1.
        N Engl J Med. 2020; 382: 1564-1567
        • Mondelli M.U.
        • Colaneri M.
        • Seminari E.M.
        • Baldanti F.
        Bruno R. Low risk of SARS-CoV-2 transmission by fomites in real-life conditions.
        Lancet Infect Dis. 2021; 21: e112
        • Ijaz M.K.
        • Nims R.W.
        • Zhou S.S.
        • Whitehead K.
        • Srinivasan V.
        • Kapes T.
        • et al.
        Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.
        Sci Rep. 2021; 11: 5626
        • Kratzel A.
        • Todt D.
        • V’Kovski P.
        • Steiner S.
        • Gultom M.
        • Thao T.T.N.
        • et al.
        Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols.
        Emerg Infect Dis. 2020; 26: 1592-1595
        • Mentel R.
        • Shirrmakher R.
        • Kevich A.
        • Dreĭzin R.S.
        • Shmidt I.
        Virus inactivation by hydrogen peroxide.
        Vopr Virusol. 1977; : 731-733
        • Sriwilaijaroen N.
        • Wilairat P.
        • Hiramatsu H.
        • Takahashi T.
        • Suzuki T.
        • Ito M.
        • et al.
        Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
        Virol J. 2009; 6: 124
        • Nardell E.A.
        • Nathavitharana R.R.
        Airborne spread of SARS-CoV-2 and a potential role for air disinfection.
        JAMA. 2020; 324: 141-142
        • Storm N.
        • McKay L.G.A.
        • Downs S.N.
        • Johnson R.I.
        • Birru D.
        • de Samber M.
        • al at
        Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation.
        Sci Rep. 2020; 10: 22421
        • Nguyen L.H.
        • Drew D.A.
        • Graham M.S.
        • Joshi A.D.
        • Guo C.
        • Ma W.
        • et al.
        Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.
        Lancet Publ Health. 2020; 5: e475-e483
        • Burki T.
        Global shortage of personal protective equipment.
        Lancet Infect Dis. 2020; 20: 785-786
        • Haas E.J.
        • Angulo F.J.
        • McLaughlin J.M.
        • Anis E.
        • Singer S.R.
        • Khan F.
        • et al.
        Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
        Lancet. 2021; 397: 1819-1829
        • Moghadas S.M.
        • Vilches T.N.
        • Zhang K.
        • Wells C.R.
        • Shoukat A.
        • Singer B.H.
        • et al.
        The impact of vaccination on COVID-19 outbreaks in the United States.
        Clin Infect Dis. 2021; https://doi.org/10.1093/cid/ciab079
        • Tenforde M.W.
        • Olson S.M.
        • Self W.H.
        • Talbot H.K.
        • Lindsell C.J.
        • Steingrub J.S.
        • et al.
        MMWR Morb Mortal Wkly Rep. 2021; 70: 674-679
        • Gidari A.
        • Sabbatini S.
        • Bastianelli S.
        • Pierucci S.
        • Busti C.
        • Bartolini D.
        • et al.
        SARS-CoV-2 survival on surfaces and the effect of UV-C light.
        Viruses. 2021; 13
        • Biryukov J.
        • Boydston J.A.
        • Dunning R.A.
        • Yeager J.J.
        • Wood S.
        • Reese A.L.
        • et al.
        Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces.
        mSphere. 2020; 5
        • Casanova L.M.
        • Jeon S.
        • Rutala W.A.
        • Weber D.J.
        • Sobsey M.D.
        Effects of air temperature and relative humidity on coronavirus survival on surfaces.
        Appl Environ Microbiol. 2010; 76: 2712-2717
        • Gamble A.
        • Fischer R.J.
        • Morris D.H.
        • Yinda K.C.
        • Munster V.J.
        • Lloyd-Smith J.O.
        Heat-treated virus inactivation rate depends strongly on treatment procedure.
        bioRxiv. 2020; https://doi.org/10.1101/2020.08.10.242206
        • Wood A.
        • Payne D.
        The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses.
        J Hosp Infect. 1998; 38: 283-295
        • Rabenau H.F.
        • Kampf G.
        • Cinatl J.
        • Doerr H.W.
        Efficacy of various disinfectants against SARS coronavirus.
        J Hosp Infect. 2005; 61: 107-111
        • Hulkower R.L.
        • Casanova L.M.
        • Rutala W.A.
        • Weber D.J.
        • Sobsey M.D.
        Inactivation of surrogate coronaviruses on hard surfaces by health care germicides.
        Am J Infect Control. 2011; 39: 401-407
        • Bedell K.
        • Buchaklian A.H.
        • Perlman S.
        Efficacy of an automated multiple emitter whole-room ultraviolet-C disinfection system against coronaviruses MHV and MERS-CoV.
        Infect Control Hosp Epidemiol. 2016; 37: 598-599
        • Anderson E.R.
        • Hughes G.L.
        • Patterson E.I.
        Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.
        bioRxiv. 2020; https://doi.org/10.1101/2020.11.25.394288
        • Behzadinasab S.
        • Chin A.
        • Hosseini M.
        • Poon L.
        • Ducker W.A.
        A surface coating that rapidly inactivates SARS-CoV-2.
        ACS Appl Mater Interfaces. 2020; 12: 34723-34727
        • Colnago L.A.
        • Trevisol I.M.
        • Voss Rech D.
        • Forato L.A.
        • Igreja do Nascimento Mitre C.
        • Gagliardi L.J.P.
        • et al.
        Simple, low-cost and long-lasting film for virus inactivation using avian coronavirus model as Challenge.
        Int J Environ Res Public Health. 2020; 17
        • Gerchman Y.
        • Mamane H.
        • Friedman N.
        • Mandelboim M.
        UV-LED disinfection of coronavirus: wavelength effect.
        J Photochem Photobiol B-Biol. 2020; 212: 7
        • Heilingloh C.S.
        • Aufderhorst U.W.
        • Schipper L.
        • Dittmer U.
        • Witzke O.
        • Yang D.
        • et al.
        Susceptibility of SARS-CoV-2 to UV irradiation.
        Am J Infect Control. 2020; 48: 1273-1275
        • Khaiboullina S.
        • Uppal T.
        • Dhabarde N.
        • Subramanian V.R.
        • Verma S.C.
        Inactivation of human coronavirus by titania nanoparticle coatings and UVC radiation: throwing light on SARS-CoV-2.
        Viruses. 2020; 13
        • Liu S.F.
        • Luo W.
        • Li D.
        • Yuan Y.
        • Tong W.
        • Kang J.J.
        • et al.
        Sec-eliminating the SARS-CoV-2 by AlGaN based high power deep ultraviolet light source.
        Adv Funct Mater. 2020; (7)https://doi.org/10.1002/adfm.202008452
        • Malenovská H.
        Coronavirus persistence on a plastic carrier under refrigeration conditions and its reduction using wet wiping technique, with respect to food safety.
        Food Environ Virol. 2020; 12: 361-366
        • Martins R.B.
        • Castro I.A.
        • Pontelli M.
        • Souza J.P.
        • Lima T.M.
        • Melo S.R.
        • et al.
        SARS-CoV-2 inactivation by ozonated water: a preliminary alternative for environmental disinfection.
        Ozone Sci Eng. 2021; 43: 108-111
        • Meyers C.
        • Kass R.
        • Goldenberg D.
        • Milici J.
        • Alam S.
        • Robison R.
        Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
        J Hosp Infect. 2020; https://doi.org/10.1016/j.jhin.2020.09.026
        • Monge F.A.
        • Jagadesan P.
        • Bondu V.
        • Donabedian P.L.
        • Ista L.
        • Chi E.Y.
        • et al.
        Highly effective inactivation of SARS-CoV-2 by conjugated polymers and oligomers.
        ACS Appl Mater Interfaces. 2020; 12: 55688-55695
        • Ratnesar-Shumate S.
        • Williams G.
        • Green B.
        • Krause M.
        • Holland B.
        • Wood S.
        • et al.
        Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces.
        J Infect Dis. 2020; 222: 214-222
        • Criscuolo E.
        • Diotti R.A.
        • Ferrarese R.
        • Alippi C.
        • Viscardi G.
        • Signorelli C.
        • et al.
        Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials.
        Emerg Microbes Infect. 2021; https://doi.org/10.1080/22221751.2021.1872354
        • Franke G.
        • Knobling B.
        • Brill F.H.
        • Becker B.
        • Klupp E.M.
        • Belmar Campos C.
        • et al.
        An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2.
        J Hosp Infect. 2021; 112: 108-113
        • Hu X.
        • Chen Z.
        • Su Z.
        • Deng F.
        • Chen X.
        • Yang Q.
        • et al.
        Ozone water is an effective disinfectant for SARS-CoV-2.
        Virol Sin. 2021; https://doi.org/10.1007/s12250-021-00379-7
        • Messina G.
        • Della Camera A.
        • Ferraro P.
        • Amodeo D.
        • Corazza A.
        • Nante N.
        • et al.
        Int J Environ Res Public Health. 2021; 18
        • Steinhauer K.
        • Meister T.L.
        • Todt D.
        • Krawczyk A.
        • Paßvogel L.
        • Becker B.
        • et al.
        Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
        J Hosp Infect. 2021; 111: 180-183
        • Trivellin N.
        • Buffolo M.
        • Onelia F.
        • Pizzolato A.
        • Barbato M.
        • Orlandi V.T.
        • et al.
        Inactivating SARS-CoV-2 using 275 nm UV-C LEDs through a spherical irradiation box: design, characterization and validation.
        Materials (Basel). 2021; 14
        • Uppal T.
        • Khazaieli A.
        • Snijders A.M.
        • Verma S.C.
        Inactivation of human coronavirus by FATHHOME's dry sanitizer device: rapid and eco-friendly ozone-based disinfection of SARS-CoV-2.
        Pathogens. 2021; 10
        • Eggers M.
        • Eickmann M.
        • Zorn J.
        Rapid and effective virucidal activity of povidone-iodine products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA).
        Infect Dis Ther. 2015; 4: 491-501
        • Bidra A.S.
        • Pelletier J.S.
        • Westover J.B.
        • Frank S.
        • Brown S.M.
        • Tessema B.
        Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses.
        J Prosthodont. 2020; 29: 599-603
        • Bidra A.S.
        • Pelletier J.S.
        • Westover J.B.
        • Frank S.
        • Brown S.M.
        • Tessema B.
        Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse.
        J Prosthodont. 2020; 29: 529-533
        • Frank S.
        • Brown S.M.
        • Capriotti J.A.
        • Westover J.B.
        • Pelletier J.S.
        • Tessema B.
        In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2.
        JAMA Otolaryngol Head Neck Surg. 2020; 146: 1-5
        • Gudmundsdottir Á.
        • Scheving R.
        • Lindberg F.
        • Stefansson B.
        Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
        J Med Virol. 2020; https://doi.org/10.1002/jmv.26554
        • Leslie R.A.
        • Zhou S.S.
        • Macinga D.R.
        Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers.
        Am J Infect Control. 2020; https://doi.org/10.1016/j.ajic.2020.08.020
        • Liang B.
        • Yuan X.
        • Wei G.
        • Wang W.
        • Zhang M.
        • Peng H.
        • et al.
        In-vivo toxicity studies and in-vitro inactivation of SARS-CoV-2 by povidone-iodine in-situ gel forming formulations.
        bioRxiv. 2020; https://doi.org/10.1101/2020.05.18.103184
        • Meister T.L.
        • Brüggemann Y.
        • Todt D.
        • Conzelmann C.
        • Müller J.A.
        • Groß R.
        • et al.
        Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2.
        J Infect Dis. 2020; 222: 1289-1292
        • Mukherjee S.
        • Vincent C.K.
        • Jayasekera H.W.
        • Yekhe A.S.
        Antiviral efficacy of personal care formulations against severe acute respiratory syndrome coronavirus 2.
        Infect Dis Health. 2020; 26: 63-66
        • Hirose R.
        • Bandou R.
        • Ikegaya H.
        • Watanabe N.
        • Yoshida T.
        • Daidoji T.
        • et al.
        Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation.
        Clin Microbiol Infect. 2021; https://doi.org/10.1016/j.cmi.2021.04.009
        • Huang Y.H.
        • Huang J.T.
        Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients.
        J Med Virol. 2021; 93: 4370-4373
        • Steinhauer K.
        • Meister T.L.
        • Todt D.
        • Krawczyk A.
        • Paßvogel L.
        • Becker B.
        • et al.
        Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2.
        J Hosp Infect. 2021; 112: 27-30
        • Frank S.
        • Capriotti J.
        • Brown S.M.
        • Tessema B.
        Povidone-iodine use in Sinonasal and oral cavities: a review of safety in the COVID-19 era.
        Ear Nose Throat J. 2020; 99: 586-593
        • He H.
        • Dong X.
        • Yang M.
        • Yang Q.
        • Duan S.
        • Yu Y.
        • et al.
        Catalytic inactivation of SARS coronavirus, Escherichia coli and yeast on solid surface.
        Catal Commun. 2004; 5: 170-172
        • Buonanno M.
        • Welch D.
        • Shuryak I.
        • Brenner D.J.
        Far-UVC light (222nm)efficiently and safely inactivates airborne human coronaviruses.
        Sci Rep. 2020; 10: 10285
        • Qiao Y.
        • Yang M.
        • Marabella I.A.
        • McGee D.A.J.
        • Aboubakr H.
        • Goyal S.
        • et al.
        Greater than 3-log reduction in viable coronavirus aerosol concentration in ducted ultraviolet-C (UV-C) systems.
        Environ Sci Technol. 2020; https://doi.org/10.1021/acs.est.0c05763
        • Yu L.
        • Peel G.K.
        • Cheema F.H.
        • Lawrence W.S.
        • Bukreyeva N.
        • Jinks C.W.
        • et al.
        Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.
        Mater Today Phys. 2020; 15: 5
        • Blanchard E.L.
        • Lawrence J.D.
        • Noble J.A.
        • Xu M.
        • Joo T.
        • Ng N.L.
        • et al.
        Enveloped virus inactivation on personal protective equipment by exposure to ozone.
        medRxiv. 2020; https://doi.org/10.1101/2020.05.23.20111435
        • Campos R.K.
        • Jin J.
        • Rafael G.H.
        • Zhao M.
        • Liao L.
        • Simmons G.
        • et al.
        Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities.
        Acs Nano. 2020; 14: 14017-14025
        • Choi Y.W.
        • Richardson A.W.
        • Sunderman M.
        • Mladineo M.J.
        • Keyes P.H.
        • Hofacre K.C.
        • et al.
        Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators (FFRs) with moist heat generated by a multicooker.
        Lett Appl Microbiol. 2020; https://doi.org/10.1111/lam.13443
        • Daeschler S.C.
        • Manson N.
        • Joachim K.
        • Chin A.W.H.
        • Chan K.
        • Chen P.Z.
        • et al.
        Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function.
        CMAJ. 2020; 192: E1189-E1197
        • Gopal V.
        • Nilsson-Payant B.E.
        • French H.
        • Siegers J.Y.
        • Yung W.S.
        • Hardwick M.
        • et al.
        Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus.
        bioRxiv. 2020; https://doi.org/10.1101/2020.11.02.365833
        • Ibanez-Cervantes G.
        • Bravata-Alcantara J.C.
        • Najera-Cortes A.S.
        • Meneses-Cruz S.
        • Delgado-Balbuena L.
        • Cruz-Cruz C.
        • et al.
        Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices.
        Am J Infect Control. 2020; 48: 1037-1041
        • Ludwig-Begall L.F.
        • Wielick C.
        • Dams L.
        • Nauwynck H.
        • Demeuldre P.F.
        • Napp A.
        • et al.
        The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus.
        J Hosp Infect. 2020; 106: 577-584
        • Ma Q.X.
        • Shan H.
        • Zhang C.M.
        • Zhang H.L.
        • Li G.M.
        • Yang R.M.
        • et al.
        Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports.
        J Med Virol. 2020; 92: 1971-1974
        • Mantlo E.
        • Rhodes T.
        • Boutros J.
        • Patterson-Fortin L.
        • Evans A.
        • Paessler S.
        In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation.
        F1000Res. 2020; 9: 674
        • Ozog D.M.
        • Sexton J.Z.
        • Narla S.
        • Pretto-Kernahan C.D.
        • Mirabelli C.
        • Lim H.W.
        • et al.
        The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2.
        Int J Infect Dis. 2020; 100: 224-229
        • Perkins D.J.
        • Nofchissey R.A.
        • Ye C.
        • Donart N.
        • Kell A.
        • Foo-Hurwitz I.
        • et al.
        COVID-19 global pandemic planning: dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV-2 on N95 respirators.
        Exp Biol Med. 2020; https://doi.org/10.1177/1535370220977819
        • Rathnasinghe R.
        • Karlicek R.F.
        • Schotsaert M.
        • Koffas M.A.
        • Arduini B.
        • Jangra S.
        • et al.
        Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device.
        medRxiv. 2020; https://doi.org/10.1101/2020.10.05.20206953
        • Rockey N.
        • Arts P.J.
        • Li L.
        • Harrison K.R.
        • Langenfeld K.
        • Fitzsimmons W.J.
        • et al.
        Humidity and deposition solution play a critical role in virus inactivation by heat treatment of N95 respirators.
        mSphere. 2020; 5
        • Glasbrenner D.C.
        • Choi Y.W.
        • Richardson A.W.
        • Edwards E.W.
        • Mladineo M.J.
        • Sunderman M.
        • et al.
        Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators using artificial sun lamps.
        J Appl Microbiol. 2021; https://doi.org/10.1111/jam.15106
        • Valdez-Salas B.
        • Beltran-Partida E.
        • Cheng N.
        • Salvador-Carlos J.
        • Valdez-Salas E.A.
        • Curiel-Alvarez M.
        • et al.
        Promotion of surgical masks antimicrobial activity by disinfection and impregnation with disinfectant silver nanoparticles.
        Int J Nanomed. 2021; 16: 2689-2702
        • Rojas-Valencia M.N.
        Research on ozone application as disinfectant and action mechanisms on wastewater microorganisms.
        in: Méndez-Vilas A. Science against microbial pathogens: communicating current research and technological advances. National Autonomous University of Mexico, Institute of Engineering, Coordination of Environmental Engineering, Mexico2011
        • Nuvolone D.
        • Petri D.
        • Voller F.
        The effects of ozone on human health.
        Environ Sci Pollut Res Int. 2018; 25: 8074-8088
        • Suchomel M.
        • Steinmann J.
        • Kampf G.
        Efficacies of the original and modified World Health Organization-recommended hand-rub formulations.
        J Hosp Infect. 2020; 106: 264-270
        • Rabenau H.F.
        • Cinatl J.
        • Morgenstern B.
        • Bauer G.
        • Preiser W.
        • Doerr H.W.
        Stability and inactivation of SARS coronavirus.
        Med Microbiol Immunol. 2005; 194: 1-6
        • Binda G.
        • Bellasi A.
        • Spanu D.
        • Pozzi A.
        • Cavallo D.
        • Bettinetti R.
        Evaluating the environmental impacts of personal protective equipment use by the general population during the COVID-19 pandemic: a case study of Lombardy (Northern Italy).
        Environments. 2021; 8: 33
        • Rizan C.
        • Reed M.
        • Bhutta M.F.
        Environmental impact of personal protective equipment distributed for use by health and social care services in England in the first six months of the COVID-19 pandemic.
        J R Soc Med. 2021; 114: 250-263
        • Zhang E.J.
        • Aitchison L.P.
        • Phillips N.
        • Shaban R.Z.
        • Kam A.W.
        Protecting the environment from plastic PPE.
        BMJ. 2021; 372: n109
        • Eggers M.
        • Schwebke I.
        • Suchomel M.
        • Fotheringham V.
        • Gebel J.
        • Meyer B.
        • et al.
        The European tiered approach for virucidal efficacy testing – rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases.
        Euro Surveill. 2021; 26